return to previous page
CellMiner Address: https://discover.nci.nih.gov/cellminer/
CellMiner Database Version: 2.16
Human Genome Version: HG-19
Date: 10-28-2026
Table 2: HTS384 NCI-60 Drug List

NSC	Drug name	Clinical status	Mechanism of action	PubChem SID
740	Methotrexate	FDA approved	Df|DHFR	67627
750	Busulfan	FDA approved	A7|AlkAg	67633
752	Thioguanine	FDA approved	Ds|IMPDH2|IMPDH	538243
755	6-Mercaptopurine	FDA approved	Ds|PPAT	538245
762	Nitrogen mustard hydrochloride	FDA approved	A7|AlkAg	538248
1390	Allopurinol	FDA approved	AM|XDH	68199
3053	Dactinomycin	FDA approved	Db|RNA polymerase I	538571
3088	Chlorambucil	FDA approved	A7|AlkAg	69624
6396	Thiotepa	FDA approved	A7|AlkAg	72371
8806	Melphalan	FDA approved	A7|AlkAg	301128
9706	Triethylenemelamine	-	A7|AlkAg	75085
13875	Hexamethylmelamine	FDA approved	Db|AlkAg	78208
14229	Quinacrine	Clinical trial	Db|AP	301135
18509	Aminolevulinic Acid Hydrochloride	FDA approved	AM	541468
19893	Fluorouracil	FDA approved	Ds|Rs|TYMS	82653
24559	Mithramycin	FDA approved	Db|Rs	85982
25154	Pipobroman	FDA approved	A7|AlkAg	86412
26271	Cyclophosphamide	FDA approved	A7|AlkAg	87150
26980	Mitomycin	FDA approved	A2|AlkAg	87663
27640	Floxuridine	FDA approved	Ds|TYMS	88034
32065	Hydroxyurea	FDA approved	AM|Dr	90752
34462	Uracil mustard	FDA approved	A7|AlkAg	92079
36405	Chelerythrine, chloride	-	BCL2|PK:PRKCA,STK	544923
38721	Mitotane	FDA approved	A7|Ho|AlkAg|anti-Ho|CYP11A1	94579
45388	Dacarbazine	FDA approved	A7|AlkAg	99125
45923	8-Methoxypsoralen	FDA approved	Db	99459
49842	Vinblastine sulfate	FDA approved	TUBB|Tu-frag	101900
62343	Bromopyruvic Acid	-	Mito|HK2	109484
63878	Cytarabine hydrochloride	FDA approved	Ds	549052
66847	Thalidomide	FDA approved	Ang|Immunomodulatory	111716
67574	Vincristine sulfate	FDA approved	TUBB|Tu-frag	112141
71423	Megestrol acetate	FDA approved	Ho|PGR	114395
75520	Trifluridine	FDA approved	TYMS	117087
77213	Procarbazine hydrochloride	FDA approved	A7|AlkAg	551000
79037	Lomustine	FDA approved	A6|AlkAg	119147
82151	Daunorubicin hydrochloride	FDA approved	TOP2	301154
85998	Streptozocin	FDA approved	A7|AlkAg	123022
92859	Trisenox 3	FDA approved	Apo	398774
102816	Azacitidine	FDA approved	DNMT	405114
105014	Cladribine	FDA approved	Ds|ADA	405818
109724	Ifosfamide	FDA approved	A7|AlkAg	301170
118218	Fludarabine Base	FDA approved	Ds|AM|Dr|STAT1	413479
119875	Cisplatin	FDA approved	A7|AlkAg	301178
122758	Tretinoin	FDA approved	Ho|RXR|Differentiator	416403
122819	Teniposide	FDA approved	TOP2	416461
123127	Doxorubicin hydrochloride	FDA approved	TOP2	301181
125066	Bleomycin	FDA approved	Db	301184
125973	Paclitaxel	FDA approved	TUBB|Tu-stab	418145
127716	Decitabine	FDA approved	AM|DNMT	419300
130181	Tirapazamine	Clinical trial	DDI	557658
138783	Bendamustine Hydrochloride	FDA approved	A2|A6|AlkAg	558674
141540	Etoposide	FDA approved	TOP2	427063
142784	Tempol	Clinical trial	RP|FRS	427794
169780	ICRF-187	FDA approved	TOP2|NonCan:Cardioprotective	442425
180973	Tamoxifen citrate	FDA approved	Ho|SERM	447264
218321	Pentostatin	FDA approved	Ds|AM|ADA	129792
221019	Wortmannin	-	PK:PIK3	130227
226080	Rapamycin	FDA approved	PK:STK,MTOR	131458
241240	Carboplatin	FDA approved	A7|AlkAg	568180
246131	Valrubicin	FDA approved	TOP2	136463
256439	Idarubicin hydrochloride	FDA approved	TOP2	569326
256942	Epirubicin HCL	FDA approved	TOP2	569372
266046	Oxaliplatin	FDA approved	A7|AlkAg	569872
279836	Mitoxantrone	FDA approved	TOP2	142727
296961	Ethiofos	FDA approved	RP	147094
312887	Fludarabine phosphate	FDA approved	Ds|AM|Dr|STAT1	455602
330507	Tanespimycin	Clinical trial	HSP90	574817
350625	ONC 201	Clinical trial	-	463349
362856	Temozolomide	FDA approved	A7|AlkAg	465959
369100	Imiquimod	FDA approved	AM|TLR7|ImmuneResMod	48426262
372278	2-Anthracen-9-yl-6,7-dimethyl-4,9-dihydrofuro[3,2-b]quinoxalin-3-one	-	-	468294
372868	ethyl 5-[(E)-2-(2,4-dichlorophenyl)ethenyl]-1,2-oxazole-3-carboxylate	-	-	468560
372870	4,5-Bis(2-nitroanilino)cyclopent-2-en-1-one	-	-	468562
372964	N-Desmethyltamoxifen hydrochloride	-	-	577474
375390	[8-[2-(Dimethylamino)ethylamino]-9-oxothioxanthen-2-yl] 4-methylbenzenesulfonate	-	-	469237
376283	3-(Dimethylamino)-2-[(dimethylamino)methyl]-1-(2,4,5-trimethoxyphenyl)propan-1-one;hydrochloride	-	-	577691
377130	[4-(dimethylcarbamoyl)phenyl] N-benzylcarbamodithioate	-	-	469536
377318	8-{[2-(dimethylamino)ethyl]amino}-5-(hydroxymethyl)-9-oxo-9H-thioxanthen-2-yl 4-methylbenzenesulfonate	-	-	469584
377391	4-Cyanophenyl 3,5-dichlorophenylcarbamate	-	-	469604
377850	(5-chloroquinolin-8-yl) N-(3-bromophenyl)carbamate	-	-	469695
377851	Mls003171375	-	-	469696
378679	1, N,N'-bis(9-acridinyl)-, dihydrochloride	-	-	577863
378879	(E)-1-(3,4-dichlorophenyl)-5-[2-(dimethylamino)ethyl-methylamino]-4,4-dimethylpent-1-en-3-one;hydrobromide	-	-	577881
380726	[5-(3,4-dichlorophenyl)-7-(propan-2-ylcarbamoyloxymethyl)-2,3-dihydropyrrolo[2,1-b][1,3]thiazol-6-yl]methyl N-propan-2-ylcarbamate	-	-	470418
380771	(E)-1-(4-chlorophenyl)-5-[2-(dimethylamino)ethyl-methylamino]-4,4-dimethylpent-1-en-3-one;hydrobromide	-	-	577993
400823	4-Thiazolecarboxylic acid, propyl ester	-	-	471868
401103	2,3-Dichloro-2,3-dihydronaphthalene-1,4-dione	-	-	472078
401134	N1,N1-Dimethyl-1,4-naphthalenediamine Hydrochloride	-	-	578421
401139	2-Amino-3-chloroanthraquinone	-	-	472111
401163	(4e)-4-{[4-(Dimethylamino)phenyl]imino}-3-methylcyclohexa-2,5-dien-1-one	-	-	472130
401379	(1E)-1-[amino-(phenanthren-3-ylamino)methylidene]-2-propan-2-ylguanidine;hydrochloride	-	-	578460
401519	Michler's ethylene	-	-	472414
409962	Carmustine	FDA approved	A7|AlkAg	479311
527453	Diethyl 2-[[3-[4-[bis(2-chloroethyl)amino]phenyl]-2-formamidopropanoyl]amino]pentanedioate	-	-	482591
601331	(E)-1-(2,6-dichlorophenyl)-5-(dimethylamino)-4-[(dimethylamino)methyl]-4-methylpent-1-en-3-one;hydrochloride	-	-	483376
606869	Clofarabine	FDA approved	Ds	484621
608210	Vinorelbine tartrate	FDA approved	TUBB|Tu-frag	485117
609699	Topotecan hydrochloride	FDA approved	TOP1	580652
613327	Gemcitabine HCL	FDA approved	Ds	486649
616348	Irinotecan HCL	FDA approved	TOP1	487652
628503	Docetaxel	FDA approved	TUBB|Tu-stab	494081
637037	6-O-Benzylguanine	Clinical trial	DDR|MGMT	498466
639186	Raltitrexed	Clinical trial	Ds|DHFR|TYMS	499545
639966	Perifosine	Clinical trial	PK:STK,AKT,AKT1,AKT2,AKT3	499931
649890	Flavopiridol	Clinical trial	CCNT1|PK:STK,CDK,CDK1,CDK2,CDK4,CDK6,CDK7,CDK8,CDK9	504654
673596	SN 38	Clinical trial	TOP1	515301
678515	FAU	-	Db	517728
679828	PD 98059	-	PK:STK,MAP2K,MAP2K1,MAP2K2	518213
683863	Irofulven	Clinical trial	Apo|AlkAg|RDI	520035
683864	Temsirolimus	FDA approved	PK:STK,MTOR	520036
686288	Aminoflavone	Clinical trial	Db|DDI	521002
698215	XK-469R	-	TOP2	525927
701554	Roscovitine	Clinical trial	PK:STK,CDK,CDK2,CDK7,CDK9	527377
701852	Vorinostat	FDA approved	HDAC	48426290
702294	Estramustine disodium phosphate	FDA approved	A7|TUBB|AlkAg	527655
703081	3'',4''-Diacetylafzelin	-	RPS6	48426291
707545	Geldanamycin, monohydrochloride	Clinical trial	HSP90	529444
710464	AFP-464	Clinical trial	Db|DDI	530822
712807	Capecitabine	FDA approved	Ds|TYMS	531878
713563	Exemestane	FDA approved	Ho|CYP19A1	532118
715055	Gefitinib	FDA approved	PK:YK,EGFR	532631
718781	Erlotinib HCL	FDA approved	PK:YK,EGFR	534851
719276	Fulvestrant	FDA approved	AM|Ho|ESR|SERM	534986
719344	Anastrozole	FDA approved	Ho|CYP19A1	535026
719345	Letrozole	FDA approved	Ho|CYP19A1	535027
719627	Celecoxib	FDA approved	AM|PTGS2|COX2|NonCan:NSAID	535138
721517	Zoledronic Acid	FDA approved	AM|NonCan:Anti-bone resorp	536160
721782	Indoximod	Clinical trial	AM|INDO|IDO1|PK:ROS1	536240
722134	(Bis-allyl)amino-wortmannin	Clinical trial	PK:PIK3	440804514
727859	(-)-Gossypol/0.1 methyl-t-butyl ether/0.7 hexane	Clinical trial	Apo|BCL2	48427549
732517	Dasatinib	FDA approved	BCR-ABL|PK:YK,PDGFR,KIT	48429642
733504	Everolimus	FDA approved	PK:STK,MTOR	48430111
737754	Pazopanib hydrochloride	FDA approved	PK:YK,PDGFR,FGFR,KIT,VEGFR	48431568
741078	Selumetinib	FDA approved	PK:STK,YK,MAP2K,MAP2K1,MAP2K2	91146061
741899	2-(4-(4-chlorophenoxy)phenyl)-1H-benzimidazole-5-carboxamide	-	PK:CHEK,CHEK2	91146360
743414	Imatinib	FDA approved	BCR-ABL|PK:YK	91146949
745750	Lapatinib	FDA approved	PK:STK,YK,MET,EGFR,ERBB2,KIT,RAF,VEGFR	91147938
746861	Englerin A, previously englerin J	-	-	528744639
747599	Nilotinib	FDA approved	BCR-ABL|PK:YK	91148446
747971	Sorafenib	FDA approved	PK:YK,PDGFR,BRAF,KIT,VEGFR,Multikinase	91148447
747972	Lenalidomide	FDA approved	FT|Immunomodulatory	91148448
747973	Ixabepilone	FDA approved	TUBB|Tu-stab	91148449
747974	Raloxifene	FDA approved	Ho|SERM	91148450
749226	Abiraterone	FDA approved	Ho|CYP17A1	131408327
750690	Sunitinib (free base)	FDA approved	PK:YK,PDGFR,KIT,VEGFR,Multikinase	91148451
750691	Afatinib	FDA approved	PK:YK,EGFR	131407778
751249	Dactolisib	Clinical trial	PK:STK,PIK3,MTOR	131407083
751297	Ximelegatran	Clinical trial	RHO	440815472
752493	Iniparib	Clinical trial	PARP|PARP1|PARP2	440815473
752840	Veliparib	Clinical trial	PARP|PARP1|PARP2	440801769
753686	Olaparib	FDA approved	PARP|PARP1	440806628
754143	Romidepsin	FDA approved	HDAC	131408687
754230	Pralatrexate	FDA approved	Df|CTNNB1|DHFR	131408688
754344	Rigosertib	Clinical trial	RAS|Tu-stab|PK:STK,PLK1	440815474
754345	4-cyano-N-(2-(1-cyclohexen-1-yl)-4-(1-((dimethylamino)acetyl)-4-piperidinyl)phenyl)-1H-imidazole-2-carboxamide	-	PK:YK,CSF1R	440812810
754346	Amg-458	-	PK:YK,MET	440812811
754348	Nirogacestat	FDA approved	PSM|APH1|Gamma secretase	440810047
754349	Amuvatinib	Clinical trial	RAD51|PK:YK,PDGFR,KIT,FLT3,Multikinase	440804515
754350	CID 9927617	-	Sig2Rec	440798880
754352	MK 1775	Clinical trial	PK:STK,YK,WEE1	440798881
754353	Buparlisib	Clinical trial	PK:PIK3	440812812
754354	5-(6-((4-Methyl-1-piperazinyl)methyl)-1H-benzimidazol-1-yl)-3-((1R)-1-(2-(trifluoromethyl)phenyl)ethoxy)-2-thiophenecarboxamide	-	PK:STK,PLK1	440804516
754355	Niraparib	FDA approved	PARP|PARP1|PARP2	440804052
754356	PF-562271	-	PK:YK,FAK	440796019
754357	Raf265	Clinical trial	GTPase|PK:BRAF	440807229
754358	(3S)-4-[(1R)-1-(2-amino-4-chlorophenyl)ethyl]-3-(4-chlorophenyl)-7-iodo-1-[3-(4-methylpiperazin-1-yl)propyl]-3H-1,4-benzodiazepine-2,5-dione	-	Apo|MDM2	440798882
754359	Aeg-40730 (iap)	-	Apo|IAP	440798883
754360	MI-219 (Mdm-2)	-	Apo|MDM2	440801770
754361	1-{3-[7-(4-Fluoro-phenyl)-imidazo[1,2-a]pyridin-3-yl]-phenyl}-3-(2,2,2-trifluoro-ethyl)-urea	-	PK:YK,FGFR	440807230
754362	(E)-SB-590885	-	GTPase|PK:YK,BRAF	440804517
754364	2-(Methylthio)-6-[4-(5-{[3-(trifluoromethyl)phenyl]amino}-4H-1,2,4-triazol-3-yl)-phenoxy]-pyrimidin-4-amine	-	GTPase|PK:YK,PDGFR,BRAF	440812813
754365	XR-11576	-	TOP2|TOP1	440815475
754366	XR 5944	-	TOP2|TOP1	440815476
754367	N-(2-(Dimethylamino)ethyl)acridine-4-carboxamide	-	TOP2|TOP1	440812814
755384	Pemetrexed(2-)	FDA approved	Df|AM|GARTF|DHFR|TYMS	440814388
755385	Pictilisib	Clinical trial	PK:PIK3	440804518
755386	Ispinesib	Clinical trial	TUBB|CC|CDH16|KIF11|Kinesin|PK:YK	440810048
755387	Sepantronium	Clinical trial	Apo|BIRC5	440796020
755389	Bosutinib	FDA approved	STAT|BCR-ABL|STAT5A/B|PK:YK,LYN,SRC,HCK	440798884
755400	Masitinib	Clinical trial	PK:YK,PDGFR,FGFR,KIT,FGFR3	440801771
755401	Golotimod	Clinical trial	STAT|STAT3	440796021
755605	Enzalutamide	FDA approved	Ho|AR	440803814
755606	Cediranib	Clinical trial	PK:YK,VEGF,VEGFR,KDR	440796022
755761	Xav-939	-	Wnt|PK:YK,TNKS	440815477
755762	Luminespib	Clinical trial	HSP90	440815478
755763	Pimasertib	Clinical trial	PK:STK,YK,MAP2K,MAP2K1,MAP2K2	440807231
755765	GW-5074	-	GTPase|PK:RAF,RAF1	440807232
755766	protein kinase inhibitor H89	-	Protein kinase A|PK:STK,AKT1	440804519
755769	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	-	PK:PIK3	440812815
755770	Mirdametinib	FDA approved	PK:STK,MAP2K,MAP2K1	440798885
755771	Salirasib	Clinical trial	GTPase|RAS|PK:YK,MTOR	440804520
755772	Sb-203580	-	PK:STK,MAPK14,PDK1	440807233
755773	anthra(1,9-cd)pyrazol-6(2H)-one	-	PK:STK,MAPK14,MAPK8	440801772
755774	Staurosporine	-	PK:PRKCA,SRC,Multikinase	440798886
755775	Foretinib	Clinical trial	PK:YK,MET,AXL,VEGFR,KDR,RON,Multikinase	440798887
755892	Hydrastinine Hydrochloride	-	NonCan:Antihemorrhagic	144074903
755926	Nirogacestat	FDA approved	PSM|APH1|Gamma secretase	440798888
755927	WZ-4002	-	PK:YK,EGFR	440815479
755980	E-7080	FDA approved	PK:YK,PDGFR,FGFR,VEGFR,KDR,RET	440803283
755981	WP-1034	-	STAT|PK:YK,JAK	440815480
755982	Semagacestat	Clinical trial	PSM|APH1|Gamma secretase	440798889
755983	Bi 2536	Clinical trial	PK:STK,PLK1	440807234
755984	Benzoic acid, 2-phenoxy-, 2-[(5-methyl-2-furanyl)methylene]hydrazide	-	Df|CTNNB1|DHFR	440804521
755985	Nelarabine	FDA approved	Ds	144074932
755986	Vismodegib	FDA approved	SMO|PK:YK	144074933
756641	(6S,9aS)-N-benzyl-6-(4-hydroxybenzyl)-8-(naphthalen-1-ylmethyl)-4,7-dioxooctahydro-1H-pyrazino[1,2-a]pyrimidine-1-carboxamide	-	Apo|Wnt|CTNNB1	440807235
756642	Entinostat	Clinical trial	HDAC	440804522
756643	Tirbanibulin	FDA approved	PK:YK,SRC	440807236
756644	Rucaparib	FDA approved	PARP|PARP1	440799361
756645	Crizotinib	FDA approved	PK:YK,MET,ALK	131408690
756646	IWR-1-endo	-	Wnt|CTNNB1	440807237
756647	Quizartinib	FDA approved	PK:YK,PDGFR,FLT,KIT,FLT3	440796023
756648	Azd-1480	Clinical trial	PK:YK,JAK,JAK1,JAK2	440812816
756649	4-(4-(1,3-Benzodioxol-5-yl)-5-(2-pyridinyl)-1H-imidazol-2-yl)benzamide	-	TGFB1|PK:STK,GSK3B	440815481
756650	Ro 4929097	Clinical trial	PSM|APH1|Gamma secretase	440798890
756652	Linsitinib	Clinical trial	PK:YK,IGF1R	440796024
756653	SB 239063	-	PK:STK,MAPK14	440796025
756654	ZM 336372	-	GTPase|PK:BRAF,RAF,RAF1	440796026
756655	Bortezomib	FDA approved	PSM	440814387
756656	Mk-2206	Clinical trial	PK:STK,AKT,AKT1,AKT2,AKT3	440807238
756657	AR-12	Clinical trial	PK:STK,PDK1	440815482
756658	2-[4-[5-Phenanthren-2-yl-3-(trifluoromethyl)pyrazol-1-yl]phenyl]guanidine	-	PK:STK,PDK1	440807239
756659	Nintedanib	FDA approved	PK:YK,PDGFR,FGFR,VEGFR,FLT3	440801773
756660	Quercetin	Clinical trial	TOP2|AO|NonCan:COMT	440810049
756662	ethyl 2-[(5-ethoxycarbonyl-3-methyl-1H-indol-2-yl)methyl]-3-methyl-1H-indole-5-carboxylate	-	BIRC5|PK:YK	440810050
756663	Obatoclax mesylate	Clinical trial	Apo|BCL2	440807240
756874	NU-6027	-	PK:STK,ATR	440798891
756875	Nutlin 3	-	Apo|MDM2	440804523
756876	Nutlin 3	-	Apo|MDM2	440804524
756879	3-(5'-Hydroxymethyl-2'-furyl)-1-benzylindazole	-	HYP|HIF1|EPAS1	440807241
757148	Azd7762	-	PK:STK,CHEK,CHEK1,CHEK2	440815483
757149	Volasertib	Clinical trial	PK:STK,PLK1	440798892
757333	SGI-1776	Clinical trial	PK:STK,PIM1	440807242
757334	N-[6-[2-[4-[[4-(difluoromethoxy)phenyl]methyl]piperazine-1-carbonyl]-1-methylindol-5-yl]oxypyridin-3-yl]-N-methyl-4-(trifluoromethyl)benzamide	-	STAT|STAT3	440815484
757437	Salinomycin	-	Apo|Ab|CD133	440798893
757438	Plx-4720	-	GTPase|PK:BRAF	440804525
757439	Neratinib	FDA approved	PK:YK,EGFR,ERBB2	440801774
757440	Ridaforolimus	Clinical trial	PK:STK,MTOR	440796027
757441	Axitinib	FDA approved	PK:YK,PDGFR,VEGFR	144075334
757444	Defosbarasertib	Clinical trial	PK:STK,AURK	440812817
758005	Sapitinib	-	PK:YK,EGFR,ERBB2	440801775
758006	BLZ-945	-	PK:CSF1R	440815485
758007	Tivozanib	FDA approved	PK:YK,MET,PDGFR,FGFR,KIT,VEGFR,FLT3,KDR	440798894
758242	Tivantinib	Clinical trial	PK:YK,MET	440812818
758243	Bms-754807	Clinical trial	PK:YK,IGF1R	440804526
758244	Tepotinib	FDA approved	PK:YK,MET	440810051
758245	ENMD-2076	Clinical trial	PK:STK,AURK,KDR	441653615
758246	Trametinib	FDA approved	PK:STK,MAP2K,MAP2K1,MAP2K2	440803816
758247	Palbociclib	FDA approved	PK:STK,CDK,CDK4,CDK6	440812153
758248	Avutometinib	FDA approved	GTPase|PK:STK,YK,BRAF,MAP2K,RAF,MAP2K1,MAP2K2	440796028
758249	Pracinostat	Clinical trial	HDAC	440801776
758250	Sns-314	Clinical trial	PK:STK,AURK	440810052
758251	Amonafide	Clinical trial	TOP2	440804527
758252	Carfilzomib	FDA approved	PSM	440803622
758253	Omacetaxine mepesuccinate	FDA approved	Apo|Ang|Pi	440803815
758254	Ixazomib citrate	FDA approved	PSM	440795380
758256	Gedatolisib	FDA approved	PK:STK,PIK3,MTOR	440798895
758257	Prexasertib	Clinical trial	PK:STK,CHEK,CHEK1	440812819
758484	Ezatiostat	Clinical trial	GSTP1|PK:STK,ROS1	440796029
758485	BX-912	-	PK:STK,PDK1	440798896
758486	2-methoxyethyl 4-(3-hydroxyphenyl)-7-(2-methoxyphenyl)-2-methyl-5-oxo-4,6,7,8-tetrahydro-1H-quinoline-3-carboxylate	-	SMO|Hg-Smo	440796030
758487	Ponatinib	FDA approved	BCR-ABL|PK:YK	440800632
758488	Lexibulin	Clinical trial	TUBB|Tu-frag|Tu-stab	440796031
758489	Indibulin	Clinical trial	TUBB|Tu-frag|PK:PTK	440815486
758490	AMD-473	Clinical trial	A7|CC|AlkAg|IDNARep	441653641
758591	Sgx-523	-	PK:YK,MET	440798897
758773	Verubulin	Clinical trial	TUBB|Tu-frag	440798898
758774	Belinostat	FDA approved	HDAC	440803282
758871	AZD 8055	-	PK:STK,MTOR	440812820
758872	Saracatinib	Clinical trial	PK:YK,FYN,LYN,FGFR,SRC,BLK,LCK,YES1	440798899
758873	4-(4-((4'-Chloro(1,1'-biphenyl)-2-yl)methyl)-1-piperazinyl)-N-((4-(((1R)-3-(dimethylamino)-1-((phenylthio)methyl)propyl)amino)-3-nitrophenyl)sulfonyl)benzamide	-	Apo|BCL2	440796032
759094	Aminopyrimidine (Scaffold I)	-	PK:STK,AURK	440798900
759095	JNJ-38877605	Clinical trial	PK:YK,MET	440798901
759096	Triapine	Clinical trial	Dr|CC	440796033
759224	Idelalisib	FDA approved	PK:PIK3	440814879
759498	Cyc-116	-	PK:STK,AURK	440804528
759657	Quisinostat	Clinical trial	HDAC	440810053
759658	Gsk-2334470	-	PK:STK,PDK1	440807243
759659	Abt 263	Clinical trial	Apo|BCL2	440807244
759660	OSI-027 sodium salt	Clinical trial	PK:STK,MTOR	440796034
759661	Dovitinib	Clinical trial	PK:YK,MET,PDGFR,EGFR,FGFR,KIT,VEGFR,FGFR1,FGFR3,FLT3	440801777
759675	Kw-2449	Clinical trial	BCR-ABL|PK:STK,AURK,FLT,FLT3	440815488
759676	3-(4-(4-Morpholinyl)pyrido(3',2':4,5)furo(3,2-d)pyrimidin-2-yl)phenol	-	PK:PIK3,MTOR	440796035
759677	Alisertib	Clinical trial	PK:STK,AURK	440815489
759905	4SC-202	Clinical trial	HDAC	441653654
760143	Mocetinostat	Clinical trial	HDAC	440810054
760144	At-9283	-	PK:STK,AURK	440812821
760444	Tipifarnib	Clinical trial	FT|PK:YK	440796036
760536	PF-04691502	Clinical trial	PK:PIK3	440810055
760764	Vosaroxin	Clinical trial	TOP2	440815490
760765	Bms-690514	Clinical trial	PK:YK,EGFR,ERBB2,VEGFR	440801778
760766	Vandetanib	FDA approved	PK:STK,YK,PDGFR,EGFR,VEGFR,RET	131408693
760841	Tandutinib	Clinical trial	PK:YK,PDGFR,FLT,KIT,FLT3	440796037
760842	(2R,2'R)-3,3'-disulfanediylbis(2-amino-1-((S)-8-(cyclohexylmethyl)-2-phenyl-5,6-dihydroimidazo[1,2-a]pyrazin-7(8H)-yl)propan-1-one)	-	Apo|GTPase|CASP	440804530
760843	Motesanib	Clinical trial	PK:YK,PDGFR,KIT,VEGFR,KDR,RET	440801779
761068	Cabozantinib	FDA approved	PK:YK,MET,AXL,KIT,VEGFR,FLT3,RET	440814386
761069	N-(4-((3-(2-Amino-4-pyrimidinyl)-2-pyridinyl)oxy)phenyl)-4-(4-methyl-2-thienyl)-1-phthalazinamine	-	PK:STK,AURK	440810056
761070	VE-821	-	PK:STK,ATR	440804531
761188	Rabusertib	Clinical trial	PK:STK,CHEK,CHEK1	440804532
761189	Teglarinad	Clinical trial	Apo|NAMPT	440807245
761190	Panobinostat	FDA approved	HDAC	440795379
761192	Pevonedistat	Clinical trial	NFkB|NEDD8	440807246
761193	Silmitasertib	Clinical trial	CK2|PK:STK	440801780
761194	Cudc-305	Clinical trial	HSP90	440804533
761215	TAK-733	Clinical trial	PK:STK,MAP2K,MAP2K1,MAP2K2	440807247
761216	Galunisertib	Clinical trial	TGFB1|PK:GSK3B	440796038
761217	Avagacestat	Clinical trial	PSM|APH1|Gamma secretase	440796039
761266	Motexafin gadolinium	Clinical trial	Dr|TXNRD|PK:ROS1	441653614
761385	Sonidegib	FDA approved	SMO|Hg-Smo	440797627
761387	4-(4-chlorobenzyl)-1-(7H-pyrrolo(2,3-d)pyrimidin-4-yl)piperidin-4-amine	-	PK:STK,AKT,AKT1,AKT2,AKT3	440812822
761388	Plerixafor	FDA approved	CXCR4	440809221
761431	Vemurafenib	FDA approved	PK:YK,BRAF	131408691
761432	Cabazitaxel	FDA approved	TUBB|Tu-stab	131408692
761690	CP-91149	-	PYGL	440798903
761691	2-(Ethyl((5-((6-methyl-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl)amino)isothiazol-3-yl)methyl)amino)-2-methylpropan-1-ol	-	PK:STK,AURK	440801781
761692	Mk-8033	Clinical trial	PK:YK,MET	440810057
761693	3-Amino-6-[4-[[2-(dimethylamino)-1-methylethyl]sulfonyl]phenyl]-N-phenyl-2-pyrazinecarboxamide	-	PK:STK,ATR	440798904
761759	6-Des-fluoro TAK-960	-	PK:STK,PLK1	440807248
761760	Bms-536924	-	PK:YK,IGF1R	440798905
761879	3-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-cyclohepta[b]pyrrol-2-one	-	PK:YK,FLT,FLT3	440804534
761910	Ibrutinib	FDA approved	PK:YK,BTK	440794864
761931	N-[2-[(E)-2-(1H-indazol-3-yl)ethenyl]phenyl]benzamide	-	PK:YK,IGF1R	440798906
762151	Tak-901	Clinical trial	PK:STK,AURK	440801782
762152	ONX-0914 TFA salt	-	PSM	440796040
762153	N-Hydroxy-E-3-(4''-methoxybiphenyl-4-yl)-acrylamide	-	HDAC	440801783
762154	Ro3280	-	PK:STK,PLK1	440807249
762381	Ji-101	Clinical trial	PK:YK,EPHA4,PDGFR,VEGFR	440810058
762382	Izorlisib	-	PK:PIK3	440815491
762418	(R)-4-(7-Cyano-5-cyclopentyl-6-ethyl-5,6-dihydroimidazo[1,5-f]pteridin-3-ylamino)-N-(1'-(cyclopropylmethyl)-1,4'-bipiperidin-4-yl)-3-methoxybenzamide	-	PK:STK,PLK1	440796041
762419	CT-32228	-	AGPAT2|PK:YK,VEGFR	440796042
762521	Ro-4987655	-	PK:STK,MAP2K	440798907
762598	Avanbulin	-	TUBB|Tu-frag	440796043
762672	4-(2-((1R)-1-(((4-chlorophenyl)sulfonyl)-2,5-difluoroanilino)ethyl)-5-fluorophenyl)butanoic acid	-	PSM|APH1|Gamma secretase	440812823
762673	Zotiraciclib	Clinical trial	PK:STK,CDK,ERK,FLT,JAK,FLT3	440801784
762829	MK-0752	Clinical trial	PSM|APH1|Gamma secretase	440815492
763094	Jzl184	-	MGLL	440804535
763371	Ruxolitinib	FDA approved	PK:YK,JAK,JAK1,JAK2	440794653
763443	Nutlin 3	-	Apo|MDM2	440798908
763444	PF-477736	Clinical trial	PK:STK,CHEK,CHEK1	440796044
763525	Pluripotin	-	GTPase|RAS|RASA1|PK:STK,MAP3K	440801785
763526	Crenolanib [usan]	Clinical trial	PK:YK,PDGFR,KIT,VEGFR,TEK,FLT3	440796045
763527	Jzl-195	-	MGLL	440804536
763564	Emd-534085	-	CDH16|KIF11|Kinesin|PK:YK	440796046
763579	Onalespib	Clinical trial	HSP90	440804537
763758	2-[2-chloro-5-(4-pyrrolidin-1-ylpiperidin-1-yl)phenyl]-1H-benzimidazole	-	SMO	440798909
763929	Orantinib	Clinical trial	PK:YK,PDGFR,FGFR,VEGFR,KDR	440807250
763930	Cenisertib	-	PK:AURK	440810059
763931	Pf-04217903	Clinical trial	PK:MET	440807251
763932	Regorafenib	FDA approved	GTPase|PK:STK,YK,PDGFR,FGFR,KIT,MAP2K,RAF,VEGFR,KDR,RET,Multikinase	440809220
764036	Dinaciclib	Clinical trial	PK:STK,CDK,CDK1,CDK2,CDK5,CDK9	440807252
764037	BP-1-102	-	STAT|IL6|STAT3	440810060
764039	Capivasertib	FDA approved	PK:STK,AKT,AKT1,AKT2,AKT3	440807253
764040	Alectinib	FDA approved	PK:YK,ALK	440797628
764041	5-Chloro-N2-(2-methoxy-4-(4-(4-methyl-1-piperazinyl)-1-piperidinyl)phenyl)-N4-(2-((1-methylethyl)sulfonyl)phenyl)-2,4-pyrimidinediamine	-	PK:YK,ALK	440798910
764042	Binimetinib	FDA approved	PK:STK,MAP2K,MAP2K1,MAP2K2	440810061
764043	JQ1 compound	-	BRD	440804538
764090	Bms-777607	Clinical trial	PK:MET,RON	440804539
764091	Apitolisib	Clinical trial	PK:PIK3,MTOR	440812824
764092	Omipalisib	Clinical trial	PK:PIK3	440815493
764134	Dabrafenib mesylate	FDA approved	PK:BRAF	440811683
764135	Bms-599626	Clinical trial	PK:YK,EGFR,ERBB2	440804540
764136	Abexinostat	Clinical trial	HDAC	440815494
764237	Linifanib	Clinical trial	PK:YK,CSF1R,PDGFR,VEGFR,FLT3,KDR	440798911
764238	Indirubin deriv. 8a	-	PK:GSK3A	440798912
764239	Azd-4547	Clinical trial	PK:YK,FGFR,FGFR1,FGFR2,FGFR3	440810062
764276	4-amino-1-[(2R,4R,5R)-4-hydroxy-5-(hydroxymethyl)thiolan-2-yl]pyrimidin-2-one	-	-	440801144
764334	Delanzomib	Clinical trial	PSM	440798913
764481	Brivanib Alaninate	Clinical trial	PK:YK,FGFR,VEGFR,FGFR1,FGFR2,FGFR3,KDR	440815495
764487	Infigratinib	FDA approved	PK:FGFR,FGFR1,FGFR2,FGFR3,FGFR4	440796047
764488	Orteronel	Clinical trial	CYP17A1	440807254
764515	Torkinib	-	PK:MTOR	440798914
764516	ZSTK474	Clinical trial	PK:PIK3	440807255
764517	2-Cyclohexyl-6-methoxy-N-(1-(1-methylethyl)-4-piperidinyl)-7-(3-(1-pyrrolidinyl)propoxy)-4-quinazolinamine	-	EHMT2|EHMT1/2	440815496
764579	Efatutazone	Clinical trial	PPARG	440796048
764580	Mk-2461	-	PK:MET,FGFR	440798915
764581	Tucatinib	FDA approved	PK:ERBB2	440796049
764582	5-(4-Ethylbenzylidene)-2-thioxothiazolidin-4-one	-	MYC	440810063
764608	Lisavanbulin	Clinical trial	Tu-frag	440796050
764609	4-nitro-N-(2-phenylphenyl)-2,1,3-benzoxadiazol-7-amine	-	MYC	440798916
764658	Sapanisertib	Clinical trial	PK:MTOR	440812825
764659	SCH-900776	Clinical trial	PK:STK,CHEK,CHEK1	440815497
764755	Cerulenin	-	FAS|FASN|HMGCS1/2	440812826
764756	Tetrahydro-4-methylene-2-octyl-5-oxo-3-furancarboxylic acid	-	FAS|FASN	440810064
764757	Xevinapant	Clinical trial	IAP	440807256
764764	ONX-0801	Clinical trial	TYMS	440801786
764765	3-[5-[2-[[(3S)-1-(1-methylpyrazol-3-yl)sulfonylpiperidin-3-yl]amino]pyrimidin-4-yl]imidazo[2,1-b][1,3]oxazol-6-yl]phenol	-	PK:BRAF	440810065
764820	Gandotinib	Clinical trial	PK:JAK,JAK2,JAK3	440804541
764821	Alectinib	FDA approved	PK:YK,ALK	440798917
764823	Varlitinib	Clinical trial	PK:YK,EGFR,ERBB2	440815498
765395	Mpc-3100	Clinical trial	HSP90	440810066
765396	Talazoparib	FDA approved	PARP1|PARP2	440810067
765435	Ganetespib	Clinical trial	HSP90	440807257
765436	4,7-Dichloro-3-hydroxy-3-(2-(4-methoxyphenyl)-2-oxoethyl)-1,3-dihydro-2H-indol-2-one	-	ERG|ETV	440798919
765632	LY2109761	-	TGFB1|PK:GSK3B	440812827
765672	3-[[(3Z)-3-[[4-(morpholin-4-ylmethyl)-1H-pyrrol-2-yl]methylidene]-2-oxo-1H-indol-5-yl]methyl]-1,3-oxazolidin-2-one	-	PK:MET,AXL,FGFR,MERTK	440796051
765694	Bosutinib	FDA approved	STAT|BCR-ABL|STAT5A/B|PK:YK,LYN,SRC,HCK	440798162
765695	Ci-1040	Clinical trial	PK:MAP2K	440804542
765775	Gemcitabine Elaidate	Clinical trial	Ds	440796052
765776	Azd 3514	-	AR	440807258
765865	Asp-3026	-	PK:ALK	440801787
765866	Refametinib	Clinical trial	PK:MAP2K,MAP2K1,MAP2K2	440810068
765888	Dacomitinib	FDA approved	PK:EGFR,ERBB2	440796053
765889	Ilorasertib	Clinical trial	PK:AURK,VEGFR	440801788
765898	Gdc-0152	Clinical trial	IAP	440812828
765949	6-(4-((4-Ethyl-1-piperazinyl)methyl)phenyl)-N-((1R)-1-phenylethyl)-7H-pyrrolo(2,3-d)pyrimidin-4-amine	-	PK:EGFR,ERBB2,VEGF,VEGFR	440810069
765974	Alpelisib	FDA approved	PK:PIK3	440807259
766254	Oprozomib	Clinical trial	PSM	440796054
766255	2-((2-((1-(2-(Dimethylamino)acetyl)-5-methoxyindolin-6-yl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-6-fluoro-N-methylbenzamide	-	PK:IGF1R,ALK	440798920
766270	Venetoclax	FDA approved	BCL2	440801145
766271	(3Z)-5-(((2,6-Dichlorophenyl)methyl)sulfonyl)-3-((3,5-dimethyl-4-(((2R)-2-(1-pyrrolidinylmethyl)-1-pyrrolidinyl)carbonyl)-1H-pyrrol-2-yl)methylene)-1,3-dihydro-2H-indol-2-one	-	PK:MET	440804543
766288	Amg-208	Clinical trial	PK:MET	440798921
766811	Odanacatib	Clinical trial	CTSB	440804544
766819	Sotrastaurin	Clinical trial	PK:PRKCA	440801789
766820	Ralimetinib	Clinical trial	PK:MAPK14	440801790
766821	Bms-911543	Clinical trial	PK:JAK,JAK1,JAK2,JAK3	440796055
766824	(1S,2S,4R)-3-[[5-chloro-2-[(1-ethyl-6-methoxy-2-oxo-4,5-dihydro-3H-1-benzazepin-7-yl)amino]pyrimidin-4-yl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxamide	-	PK:ALK	440810070
766887	Osi-930	Clinical trial	PK:PDGFR,KIT,VEGFR,Multikinase	440810071
766888	CPI-613	Clinical trial	AEMD	440796056
766906	Tovorafenib	FDA approved	PK:BRAF,RAF,RAF1	440796057
766907	Ixazomib	FDA approved	PSM	440807260
766908	N-(2-((4-(Diethylamino)butyl)amino)-6-(3,5-dimethoxyphenyl)pyrido(2,3-d)pyrimidin-7-yl)-N'-(1,1-dimethylethyl)urea	-	PK:PDGFR,FGFR,SRC,VEGFR,FGFR1,FGFR3	440810072
766991	Gsk 690693	-	PK:AKT,AKT1,AKT2,AKT3	440798922
766992	Bay 61-3606	-	PK:SYK	440804545
767006	Nvp-aew541	-	PK:YK,IGF1R	440810073
767048	SNS-032	Clinical trial	PK:CDK,CDK2,CDK7,CDK9	440798923
767123	Saridegib	Clinical trial	SMO	440810074
767124	Enzastaurin	Clinical trial	PK:PRKCA,STK,PIK3,AKT	440796058
767125	Talazoparib	FDA approved	PARP1|PARP2	440798924
767126	Anta XV	-	SMO	440815499
767128	Birinapant	Clinical trial	IAP	440815500
767189	Vistusertib	Clinical trial	PK:MTOR	440810075
767470	Mln0905	-	PK:PLK1	440807261
767533	Bmn-673 8R,9S	FDA approved	PARP1	440798925
767598	Momelotinib	FDA approved	PK:JAK,JAK1,JAK2,JAK3	440804546
767599	I-Bet151	-	BRD	440804547
767600	Fedratinib	FDA approved	PK:FLT,JAK,FLT3,JAK2,RET	440810076
767601	Avn 944	Clinical trial	IMPDH2|IMPDH1|IMPDH	440796059
767745	Pelitrexol	Clinical trial	GARTF	440812235
767746	Nvp-adw742	-	PK:IGF1R,KIT	440812829
767896	Taladegib	Clinical trial	SMO	440812830
767897	N-[5-[3-(benzenesulfonamido)phenyl]-1H-pyrazol-3-yl]-4-(4-methylpiperazin-1-yl)benzamide	-	PK:FLT,FLT3	440815501
767898	Ipatasertib	Clinical trial	PK:AKT,AKT1,AKT2,AKT3	440804548
767951	N-(2,6-Difluorophenyl)-5-(3-(2-(5-ethyl-4-(4-(4-(methanesulfonyl)piperazin-1-yl)piperidin-1-yl)-2-methoxyanilino)pyrimidin-4-yl)imidazo(1,2-a)pyridin-2-yl)-2-methoxybenzamide	-	PK:IGF1R	440810077
767952	Ricolinostat	Clinical trial	HDAC	440804549
767953	R-1530	-	PK:PDGFR,CDK,FGFR,VEGFR,KDR,Multikinase	440812831
767954	EMD-1204831	Clinical trial	PK:MET	440798926
768011	(2S,4R)-1-(2-(1H-1,2,3-triazol-1-yl)acetyl)-4-(4-fluorobenzyl)-N-(4-(4-fluorophenoxy)phenyl)pyrrolidine-2-carboxamide	-	GEMIN2	440807262
768068	Cobimetinib	FDA approved	PK:MAP2K,MAP2K1	440795381
768069	Cobimetinib (R-enantiomer)	FDA approved	PK:MAP2K,MAP2K1	440815502
768070	PF-Akt400	-	PK:AKT	440796060
768071	Enantiomer of PF-4176340	-	PK:AKT	440815503
768072	Tak-960	Clinical trial	PK:PLK1	440807263
768073	Abemaciclib	FDA approved	PK:PIM1,CDK,CDK4,CDK6	440810078
768112	Genz-644282	Clinical trial	TOP1	440807264
768508	Gsk-2636771	Clinical trial	PK:PIK3,MTOR	440798927
768509	Snx-5422	Clinical trial	HSP90	440804550
768536	(E)-4-(2-(2-Ethoxyphenyl)hydrazono)-3-methyl-1-(4-phenylthiazol-2-yl)-1H-pyrazol-5(4H)-one	-	BCL2	440798928
768539	N-cyclohexyl-2-(3-fluoro-N-[2-[(3-fluoro-2-pyridinyl)amino]acetyl]anilino)-2-(2-methylphenyl)acetamide	-	IDH1	440804551
768593	Cep-9722	Clinical trial	PARP1	440815504
771532	Gdc-0349	Clinical trial	PK:MTOR,PIM3	440815505
771644	Arq-621	Clinical trial	CDH16|KIF11	440798929
771649	Apalutamide	FDA approved	AR	440801791
771650	At-13148	-	PK:AKT,AKT1,AKT2,AKT3	440801792
771651	N3-(4-(4-morpholinocyclohexyl)phenyl)-1-(pyridin-2-yl)-1H-1,2,4-triazole-3,5-diamine	-	PK:FLT,KIT,FLT3	440815506
771652	Sar-125844	-	PK:MET	440801793
771750	Ly-2874455	-	PK:FGFR,VEGFR,FGFR1,FGFR2,FGFR3,FGFR4	440810079
771751	Fimepinostat	Clinical trial	HDAC|PK:PIK3	440807265
771858	Tak-441	Clinical trial	SMO	440815507
772196	Lestaurtinib	Clinical trial	PK:YK,FLT,NTRK,FLT3,JAK2	440815508
772197	Merestinib	Clinical trial	PK:MET,AXL,FLT3,MERTK,MST1R,Multikinase	440804553
772198	Ly-2090314	-	PK:GSK3A,GSK3B	440804554
772254	Filanesib	Clinical trial	CDH16	440815509
772255	Filanesib	Clinical trial	CDH16	440807266
772290	C20H25N5O6S	Clinical trial	GARTF	440798930
772291	C20H25N5O6S	Clinical trial	GARTF	440801794
772351	XL888	-	HSP90	440804555
772469	Duvelisib	FDA approved	PK:PIK3	440807267
772498	Tamatinib	Clinical trial	PK:SYK	440804556
772499	Vatalanib succinate	Clinical trial	CYP19A1|PK:YK,PDGFR,KIT,VEGFR,KDR	441653594
772563	Azd-8330	Clinical trial	PK:MAP2K,MAP2K1,MAP2K2	440807268
772564	2-(N-[2-(4-cyanoanilino)acetyl]-3-fluoroanilino)-N-cyclohexyl-2-(2-methylphenyl)acetamide	-	IDH1	440810080
772595	propan-2-yl (Z)-3-[3-[3-methoxy-5-(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]prop-2-enoate	-	XPO1	440815510
772868	Lcl-161	-	IAP	440796061
772885	2-amino-4-(4-chloro-2-(2-(4-fluoro-1H-pyrazol-1-yl)ethoxy)-6-methylphenyl)-N-(2,2-difluoropropyl)-5,7-dihydro-6H-pyrrolo(3,4-d)pyrimidine-6-carboxamide	-	HSP90	440804557
772886	Apatinib	Clinical trial	PK:VEGFR	440798931
772887	Pyrrolidine-2-carboxylic acid {4-[2-(4-morpholin-4-yl-phenylamino)-pyrimidin-4-yl]-phenyl}-amide	-	PK:JAK,JAK2	440815511
772920	Sb-1578	-	PK:JAK,JAK2	440807269
772991	N-[4-[[4-(2-methoxyphenyl)-1-piperazinyl]carbonyl]phenyl]-8-quinolinesulfonamide	-	PKM	440812832
772992	Fostamatinib disodium	FDA approved	Ds|Rs|PK:YK,SYK	440812833
773094	(4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl)(2,3-difluoro-6-methoxyphenyl)methanone	-	PK:CDK,CDK1,CDK2,CDK4	440815512
773095	BGT-226 free base	Clinical trial	PK:PIK3	440798932
773096	Agi-5198	-	IDH1	440810081
773174	{4-[4-({3-[(2-Methyl-1,3-benzothiazol-6-YL)amino]-3-oxopropyl}amino)-4-oxobutyl]benzyl}propanedioic acid	-	LDHA	440801795
773230	Azd-2461	-	PARP1|PARP2	440804558
773260	(Z)-2-(2-(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)vinyl)-1,3,4-oxadiazole	-	XPO1	440812834
773261	SB-743921	Clinical trial	CDH16|KIF11	440801796
773262	MK-5108	Clinical trial	PK:AURK	440798933
773264	R-306465	-	HDAC	440812835
773265	BIIB021	Clinical trial	HSP90	440810082
773394	AT-7519	Clinical trial	RNA polymerase I|PK:CDK,CDK1,CDK2,CDK4,CDK6	440810083
774651	Cilengitide	Clinical trial	Ang|ITG	440815513
774769	Entrectinib	FDA approved	PK:ROS1,ALK	440804559
774829	Molibresib	Clinical trial	BRD	440798934
774830	Pyrazolo[4,3-h]quinazoline-3-carboxamide, 29	Clinical trial	PK:CDK,CDK1,CDK2,CDK4,CDK5,Multikinase	440796062
774831	Rebastinib	Clinical trial	BCR-ABL|PK:LYN,FGFR,SRC,VEGFR,TEK	440812836
774901	AZD-2858	-	Wnt|PK:GSK3A	441653596
774911	Bay 10-00394	Clinical trial	PK:CDK	440804560
775018	LDHA inhibitor 35	-	LDHA	440812837
775306	Palomid 529	Clinical trial	PK:PIK3,AKT,FGFR,MTOR,VEGFR	440796063
775351	Pomalidomide	FDA approved	Immunomodulatory	440800631
775636	Sch772984	-	PK:ERK,MAP3K,MAPK1	440810084
775637	Mavorixafor	FDA approved	CXCR4	440798935
775665	Vx-702	Clinical trial	PK:MAPK14	440815514
775727	9-(6-Aminopyridin-3-yl)-1-(3-(trifluoromethyl)phenyl)benzo(h)(1,6)naphthyridin-2(1H)-one	-	PK:MTOR	440812838
775771	BMS-863233	Clinical trial	PK:CDC7,CDK7,CDK9	440798936
775772	Glasdegib	FDA approved	SMO	440801797
776017	Telatinib	Clinical trial	PK:PDGFR,KIT,VEGFR,KDR	440796064
776043	Agerafenib	Clinical trial	PK:BRAF	440798937
776066	Azd-1208	-	PK:PIM1,PIM2,PIM3	440804561
776422	Ceritinib	FDA approved	PK:ALK	440806087
776762	Tesevatinib	Clinical trial	PK:EGFR,ERBB2,SRC,VEGFR	440798938
776786	P505-15	-	PK:SYK	440807270
776787	Azd3463	-	PK:IGF1R,ALK	440810085
776790	MK-0429	-	ITG	440815515
776821	Cct-241533	-	PK:CHEK,CHEK2	440807271
776996	3-(4-(4-Morpholinyl)pyrido(3',2':4,5)furo(3,2-d)pyrimidin-2-yl)phenol	-	PK:PIK3,MTOR	440815516
777109	Tazemetostat	FDA approved	EZH2	440812839
777194	Daporinad	-	NAMPT|PK:YK	440807272
777425	Taselisib	Clinical trial	PK:PIK3	440810086
777445	Gsk-1070916	-	PK:AURK	440810087
777446	Talmapimod	Clinical trial	PK:MAPK14	440796065
777447	Motolimod	Clinical trial	TLR8	440807273
777448	Pfi-1	-	BRD	440798939
777571	N-(1-benzylpiperidin-4-yl)-6,7-dimethoxy-2-(4-methyl-1,4-diazepan-1-yl)quinazolin-4-amine	-	EHMT2|EHMT1/2	440810088
777572	Azd-8186	Clinical trial	PI3KB|PK:PIK3	440815517
777573	E 7820	Clinical trial	Ang|ITG	440807274
777586	5-aza-T-dCyd beta-anomer	-	-	440807987
777638	imino-methyl-[1-[6-[(3R)-3-methylmorpholin-4-yl]-2-(1H-pyrrolo[2,3-b]pyridin-4-yl)pyrimidin-4-yl]cyclopropyl]-oxo-lambda6-sulfane	Clinical trial	PK:ATR	440810089
777639	Wnt-974	Clinical trial	Wnt|PORCN	440804562
777671	Brd4770	-	EHMT2|EHMT1/2	440804563
777718	Berzosertib	Clinical trial	PK:ATR	440810090
777877	PF-4989216	-	PK:PIK3	440815518
777878	Capmatinib	FDA approved	PK:MET	440815519
777879	Cdk4/6-IN-16	-	PK:CDK,FLT,FLT3	440810091
778304	Encorafenib	FDA approved	PK:BRAF	440801798
778305	Afuresertib	Clinical trial	PK:AKT,AKT1,AKT2,AKT3	440812840
778364	Defactinib	FDA approved	PK:FAK	440812841
778365	Pinometostat	Clinical trial	DOT1L	440796066
778366	Xl-228	-	PK:IGF1R,AURK,FGFR,SRC	440798940
778367	Pexmetinib	Clinical trial	PK:MAPK14	440810092
778368	Uprosertib	Clinical trial	PK:AKT	440804564
778448	Ombrabulin	Clinical trial	TUBB|Tu-frag	440810093
778590	Gdc-0623	-	PK:MAP2K,MAP2K1	440810094
778746	FH535	-	PPARG	440804565
778747	Birabresib	Clinical trial	BRD	440815520
778809	Tak-632	-	PK:BRAF	440804566
778810	Vs-5584	Clinical trial	PK:PIK3,MTOR	440810095
778909	Ribociclib	FDA approved	PK:CDK,CDK4,CDK6	440809902
779217	Osimertinib	FDA approved	PK:EGFR	440801090
779218	Cep-28122 (alk)	-	PK:ALK	440796067
779404	Idasanutlin	Clinical trial	MDM2	440796068
779405	Rociletinib	Clinical trial	PK:EGFR	440810096
779407	Gne-617	-	NAMPT	440801799
779408	Deltarasin	-	PDE6D	440810097
780019	Canertinib dihydrochloride	Clinical trial	PK:EGFR,ERBB2	440796069
780020	Spebrutinib	Clinical trial	PK:BTK	440815521
780041	Gsk2816126	-	EZH2	440815522
780042	Cp-724714	-	PK:ERBB2	440815523
780043	Epz004777	-	DOT1L	440804567
780108	Lorlatinib	FDA approved	PK:ROS1,ALK	440810098
780163	Somcl-12-81	-	PK:ALK	440798941
780203	Selinexor	FDA approved	XPO1	440815524
780204	Pimitespib	Clinical trial	HSP90	440796070
780205	H-1152	-	RHO	440815525
780249	Ceralasertib	Clinical trial	PK:ATR	440801800
780250	(S)-Ceralasertib	Clinical trial	PK:ATR	440807275
780290	2-[2-(2-methyl-2,3-dihydro-1H-indol-1-yl)-2-oxoethyl]-6-(morpholin-4-yl)pyrimidin-4(3H)-one	-	PI3KB	440807276
780291	2-[2-(2-methyl-2,3-dihydro-1H-indol-1-yl)-2-oxoethyl]-6-(morpholin-4-yl)pyrimidin-4(3H)-one	-	PI3KB	440801801
780404	AZ505	-	SETD8|SMYD2	440812842
780812	Bms 906024	Clinical trial	APH1|Gamma secretase	440815526
780965	MK-0731	-	CDH16|KIF11	440812843
781008	Marinopyrrole A	-	MCL1	440801802
781009	(2'R,3S,4'S,5'R)-6-Chloro-4'-(3-chloro-2-fluorophenyl)-2'-(2,2-dimethylpropyl)-1,2-dihydro-N-(trans-4-hydroxycyclohexyl)-2-oxospiro[3H-indole-3,3'-pyrrolidine]-5'-carboxamide	-	MDM2	440810099
781016	1-cyclopropyl-4-(4-((5-methyl-3-(3-(4-(trifluoromethoxy)phenyl)-1,2,4-oxadiazol-5-yl)-1H-pyrazol-1-yl)methyl)pyridin-2-yl)piperazine	-	HIF1	440815527
781148	Cep-37440	Clinical trial	PK:ALK,FAK	440810100
781343	Ravoxertinib	Clinical trial	PK:ERK,MAP3K,MAPK1	440804568
781344	Onvansertib	Clinical trial	PK:PLK1	440810101
781409	Agi-6780	-	IDH2	440804569
781417	RN486	-	PK:BTK	440810102
781468	Gdc-0917	Clinical trial	IAP	440796071
781469	Bms-833923	Clinical trial	SMO	440804570
781470	PF-3758309	Clinical trial	PK:PAK4	440801803
781514	Ethanone, 1-(7,8-dihydro-2-((9-(trans-4-methylcyclohexyl)-9H-pyrido(4',3':4,5)pyrrolo(2,3-d)pyrimidin-2-yl)amino)-1,6-naphthyridin-6(5H)-yl)-2-hydroxy-	-	PK:CDK,CDK4,CDK6,FLT3	440801804
781515	Navtemadlin	Clinical trial	MDM2	440807277
781516	Entospletinib	Clinical trial	PK:SYK	440801805
781556	Erdafitinib	FDA approved	PK:FGFR,FGFR1,FGFR2,FGFR3,FGFR4	440796072
781626	Pacritinib	FDA approved	PK:YK,JAK,JAK2	440796073
781627	Gsk-2606414	-	PK:EIF2AK3	440807278
781652	Ningetinib	Clinical trial	PK:MET	440810103
781761	Ly-3009120	-	PK:BRAF,RAF1	440798942
782006	Antitumor agent-3	-	PK:RET	440812844
782007	AZ-628	-	PK:BRAF	440798943
782017	protein kinase inhibitor H89	-	Protein kinase A|PK:STK,AKT1	440815528
782121	Savolitinib	Clinical trial	PK:MET	440810104
782122	4-(2-[(5-Fluoro-6-Methoxypyridin-3-Yl)amino]-5-{(1r)-1-[4-(Methylsulfonyl)piperazin-1-Yl]ethyl}pyridin-3-Yl)-6-Methyl-1,3,5-Triazin-2-Amine	-	PK:PIK3	440796074
782125	(R)-6-[[1-(Cyclopropylcarbonyl)pyrrolidin-3-yl]methyl]-5-[4'-(1-methyl-1H-pyrazol-4-yl)[1,1'-biphenyl]-4-yl]-4,6-diazaspiro[2.4]hept-4-en-7-one	-	FASN	440804571
782153	MG-132	-	PSM	440812845
782164	Cx-5461	Clinical trial	RNA polymerase I	440801806
782310	(R)-1-(1-(1-(ethylsulfonyl)piperidin-4-yl)ethyl)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1H-indole-3-carboxamide	-	EZH2	440810105
782351	Tofacitinib	FDA approved	PK:JAK,JAK1,JAK3	440798944
782362	Pwt-33597	Clinical trial	PK:PIK3,MTOR	440815529
782363	Zoligratinib	Clinical trial	PK:PDGFR,FGFR,VEGFR,FGFR1,FGFR2,FGFR3	440796075
782457	Vby-825	-	CTSB	440801807
782549	Defactinib	FDA approved	PK:FAK	440804572
782579	Pci-27483	Clinical trial	F7	440804573
782762	Lucitanib	Clinical trial	PK:PDGFR,FGFR,VEGFR	440804574
782763	4-[(2s,4r)-1-Acetyl-4-[(4-Chlorophenyl)amino]-2-Methyl-1,2,3,4-Tetrahydroquinolin-6-Yl]benzoic Acid	-	BRD	440812846
783015	Nvp-cgm097	Clinical trial	MDM2	440801808
783102	Vs-4718	Clinical trial	PK:FAK	440804575
783107	2x-121	Clinical trial	PARP1|PARP2	440798945
783249	Jnj-26483327	Clinical trial	PK:EGFR,ERBB2,SRC,VEGFR,RET,Multikinase	440796352
783272	JNJ 47117096, 2HCL	-	PK:MELK	441653694
783294	Seviteronel	Clinical trial	CYP17A1	440804576
783296	Poziotinib	Clinical trial	PK:EGFR,ERBB2,Multikinase	440798946
783332	Epz005687	-	EZH2	440804577
783333	Sgi-1027	-	DNMT	440815530
783334	(2S)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-3-(1H-indol-3-yl)propanoic acid	-	DNMT	440812847
783360	1-[(3,4-Dimethoxyphenyl)sulfonyl]piperazine	-	DNMT	440798947
783415	Telaglenastat	Clinical trial	GLS	440812848
783916	Pyridoclax	-	MCL1	440815531
783917	Gsk-2879552	-	KDM1A	440812849
784284	Voruciclib	Clinical trial	PK:CDK,CDK1,CDK2,CDK4,CDK7,CDK9	440807279
784415	Danusertib	Clinical trial	BCR-ABL|PK:YK,AURK,FGFR,RET	440798948
784590	Altiratinib	Clinical trial	PK:MET,NTRK,VEGFR,TEK,KDR	440815532
784591	Cct251545	-	Wnt|PK:CDK19	440796076
784608	Berkeleylactone A	-	-	440795790
784722	Aldoxorubicin	Clinical trial	TOP2	440815533
784815	1-[4-[4-(1-cyclopropylsulfonylcyclopropyl)-6-[(3S)-3-methylmorpholin-4-yl]pyrimidin-2-yl]phenyl]-3-(2-hydroxyethyl)thiourea	-	PK:MTOR	440807280
784817	A-1210477	-	MCL1	440804578
784856	Pelabresib Anhydrous	Clinical trial	BRD	440796077
785004	Tak-243	Clinical trial	UB-activating	440798949
785117	Bimiralisib	Clinical trial	PK:PIK3,MTOR	440798950
785222	(2S,3R)-2-(cyclopropylmethyl)-N'-[(3S)-9-fluoro-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl]-3-(3,3,3-trifluoropropyl)butanediamide	-	APH1|Gamma secretase	440807281
785299	Epz015666	-	PRMT5	440807282
785300	Blu-9931	-	PK:FGFR,FGFR1,FGFR2,FGFR3,FGFR4	440812850
785306	Pamufetinib	Clinical trial	PK:MET,VEGFR	440798951
785345	Bet-bay 002	-	BRD	440801809
785497	Incb24360	Clinical trial	IDO1	440812851
785570	Larotrectinib	FDA approved	PK:NTRK	440810106
785657	Roducitabine	Clinical trial	DNMT	440810107
786098	Atuveciclib Racemate	Clinical trial	PK:CDK,CDK9	440798952
786099	Azd-8835	Clinical trial	PK:PIK3	440796078
786100	Cb-5083	Clinical trial	VCP	440798953
786959	Azd-9496	Clinical trial	SERD	440812852
787025	Empesertib	Clinical trial	IDUA	440807283
787026	Bay-1217389	Clinical trial	IDUA	440807284
787027	Nazartinib	Clinical trial	PK:EGFR	440810108
787038	AC710	-	PK:CSF1R,PDGFR,FLT3	440810109
787039	1-((1H-pyrazol-4-yl)methyl)-4-methyl-5-((4-((6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)methyl)-1H-indole-2-carbonitrile	-	KMT2A	440807285
787047	Azd-3965	Clinical trial	SLC16A1|SLC16A7	440815534
787048	Azd5582	-	IAP	440812853
787081	SR9243	-	NR1H1/2	440804579
787137	AMG-319	Clinical trial	PK:PIK3	440801810
787251	Lomeguatrib	-	MGMT	440810110
787252	2-((5-chloro-2-((2-methoxy-4-morpholin-4-ylphenyl)amino)pyrimidin-4-yl)amino)-N-methylbenzamide	-	PK:IGF1R,FAK	440810111
787253	Crenigacestat	Clinical trial	NOTCH	440815535
787269	2-(Butane-1-sulfinyl)-4-phenyl-6-(thiophen-2-yl)thieno(2,3-b)pyridin-3-amine	-	HPGD	440804580
787312	PT-2385	Clinical trial	EPAS1	440804581
787326	Brilanestrant	Clinical trial	SERD	440801811
787457	Brigatinib	FDA approved	PK:YK,IGF1R,ALK,EGFR	440796079
787780	Sabutoclax	-	MCL1	440798954
787827	Cfg-920	Clinical trial	CYP17A1	440807286
787846	Gilteritinib	FDA approved	PK:AXL,FLT3	440798955
787854	Gilteritinib	FDA approved	-	440815849
787880	Ots964	-	PK:PBK	440812854
787960	Umi-77	-	MCL1	440796080
787962	KU-55933	-	PK:ATM	440810112
788120	Enasidenib	FDA approved	IDH1|IDH2	440812855
788121	Zorifertinib	Clinical trial	PK:EGFR	440801812
788186	Bafetinib	Clinical trial	BCR-ABL|PK:YK,FYN,LYN	440798956
788203	Sitravatinib	Clinical trial	PK:PDGFR,AXL,NTRK,KDR,RET	440798957
788365	Mavelertinib	Clinical trial	PK:EGFR	440812856
788794	trans-4-[4-[4-(5-Fluoro-2-methoxyphenyl)-1H-pyrrolo[2,3-b]pyridin-2-yl]-3,6-dihydro-1(2H)-pyridinyl]cyclohexaneacetic acid	-	PK:CDK,CDK9	440807287
788900	Napabucasin	Clinical trial	CTNNB1|STAT3	440807288
788948	Uridine triacetate	FDA approved	TUBB|FU-Antidote	440812152
788992	Oicr-9429	-	WDR5	440798958
789040	CBL0137	Clinical trial	-	440804582
789041	Gsk-923295a	Clinical trial	CENP	440801813
789042	Apto-253	Clinical trial	KLF4|MYC|MTF1	440804583
789043	2-((S)-4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)-N-(4-(2-(2-(2-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)ethoxy)ethoxy)ethoxy)ethoxy)phenyl)acetamide	-	BRD	440807289
789044	N8-[(2S)-3,3-dimethylbutan-2-yl]-N2-[2-methoxy-4-(1-methyl-1H-pyrazol-4-yl)phenyl]pyrido[3,4-d]pyrimidine-2,8-diamine	-	IDUA	440807290
789099	Nampt-IN-1	-	NAMPT	440810113
789102	Ivosidenib	FDA approved	IDH1	440796081
789223	Amg-337	Clinical trial	PK:MET	440796082
789300	Pexidartinib	FDA approved	PK:CSF1R,KIT,FLT3	440796083
789722	Litronesib	Clinical trial	TUBB|CDH16|KIF11	440796084
789797	2-(5-ethyl-5H-[1,2,4]triazino[5,6-b]indol-3-ylthio)-N-(2-methoxyphenyl)butanamide	-	TOP1	440810114
789925	Asciminib	FDA approved	BCR-ABL	440801814
789968	Samotolisib	Clinical trial	PK:PIK3,MTOR	440801815
789969	Sb-202190	-	PK:MAPK14	440801816
790182	Alofanib	Clinical trial	PK:FGFR	440815536
790865	Epz020411	-	PRMT6	440807291
791059	Glesatinib	Clinical trial	PK:MET,VEGFR	440798959
791163	Gdc-0425	Clinical trial	PK:CHEK1	440798960
791164	Acalabrutinib	FDA approved	PK:BTK	440801817
791226	Voxtalisib	Clinical trial	PK:PIK3	440815537
791227	Pilaralisib	Clinical trial	PK:PIK3	440796085
791328	Miransertib	Clinical trial	PK:AKT	440796086
791495	Gdc-0339	-	PK:PIM1,PIM2,PIM3	440812857
791496	Eprenetapopt	Clinical trial	Apo	440796087
791648	N-[(2S)-1-[4-(2-Acetyl-1-methylimidazol-4-yl)phenyl]-3-[[2-(dimethylamino)acetyl]amino]propan-2-yl]-3-chloro-4-propan-2-yloxybenzamide	-	CENP	440801818
791783	Tomivosertib	Clinical trial	MKNK1/2	440804584
791785	Sapacitabine	Clinical trial	Ds	440801819
791966	CFI-400945 free base	Clinical trial	PK:PLK1	440798961
791967	Mivavotinib	Clinical trial	PK:SYK	440804585
791968	Mivavotinib	Clinical trial	PK:SYK	440798962
792847	Akt-IN-6	-	PK:AKT	440810115
792848	Olmutinib	Clinical trial	PK:EGFR,BTK,JAK3	440815538
792849	Itacitinib	Clinical trial	PK:JAK1	440815539
792955	Gsk2194069	-	FAS|FASN	440796088
792956	Azd-0156	Clinical trial	PK:ATM	440815540
792969	VX-984	Clinical trial	PK:PRKDC	440798963
792970	Padnarsertib	Clinical trial	PK:PAK4	440812858
792971	CC 223	Clinical trial	PK:MTOR	440807292
792987	Paxalisib	Clinical trial	PK:PIK3,MTOR	440812859
792996	Derazantinib Racemate	Clinical trial	PK:FGFR	440804680
792997	Derazantinib Racemate	Clinical trial	-	440799202
793103	Mivebresib	Clinical trial	BRD	440812860
793148	Supinoxin	Clinical trial	-	440801820
793149	Bay-876	-	SLC2A1	440812861
793150	Ensartinib	FDA approved	PK:ALK	440796089
793151	Cc-115	Clinical trial	PK:MTOR	440815541
793322	Naquotinib	Clinical trial	PK:EGFR	440812862
793323	Lifirafenib	Clinical trial	PK:BRAF	440810116
793324	Bay-1125976	-	PK:AKT,AKT2	440810117
793430	Lirametostat	Clinical trial	EZH2	440796090
793585	(R)-3-(5-fluoropyrimidin-4-yl)-3-methyl-6-(1H-pyrazol-4-yl)isoindolin-1-one	-	PK:CDC7,CDK7	440804586
793677	Asp-5878	Clinical trial	PK:FGFR	440804587
793679	DFP-10917	Clinical trial	-	440807293
793726	Sra-737	-	PK:CHEK1	440815542
793727	8-(2-amino-3-chloro-5-(1-methyl-1H-indazol-5-yl)pyridin-4-yl)-2,8-diazaspiro[4.5]decan-1-one	-	PK:CDK,CDK19	440812863
794109	Lgh-447	-	PK:PIM1	440798964
794442	5-(4,6-Di((1R,5S)-3-oxa-8-azabicyclo[3.2.1]octan-8-yl)-1,3,5-triazin-2-yl)-4-(difluoromethyl)pyridin-2-amine	-	PK:MTOR	440815543
794443	Eltanexor	Clinical trial	XPO1	440804588
794487	Bay1436032	Clinical trial	IDH1	440796091
794589	N-(2,6-diethylphenyl)-2-[2-methoxy-4-(4-methylpiperazin-1-yl)anilino]-5,6-dihydropyrimido[4,5-e]indolizine-7-carboxamide	-	PK:TTK	440804589
794590	BAY1082439	Clinical trial	PK:PIK3	440796092
794646	5-[3-Fluoro-4-[[6-methoxy-7-(3-morpholinopropoxy)quinolin-4-yl]oxy]phenyl]-2-(4-fluorophenylamino)-3-methylpyrimidin-4(3H)-one	-	PK:MET	440810118
795067	Eganelisib	Clinical trial	-	440815544
795142	M-2698	Clinical trial	PK:AKT,AKT1,AKT2,AKT3	440807294
795384	Serabelisib	Clinical trial	-	440812864
795718	Fisogatinib	Clinical trial	PK:FGFR,FGFR4	440796093
795781	N-(1-Isopropyl-3-(1-methylindolin-6-yl)-1H-pyrrolo[2,3-b]pyridin-4-yl)-1-methyl-1H-pyrazole-3-sulfonamide	-	-	440796094
796100	Pf-06840003	Clinical trial	IDO1	440801821
796101	Opaganib	Clinical trial	SPHK2	440810119
796433	PF-04136309	Clinical trial	-	440798965
797172	A-1331852	-	-	440804590
797393	5'-Sulfamoyl-2-chloroadenosine	-	HSP90	440804591
797653	8-(2-(4-(Diphenylamino)benzylidene)hydrazinyl)-N-hydroxy-8-oxooctanamide	-	HDAC	440796095
797769	4-(4-Amino-2-(p-tolylamino)thiazole-5-carbonyl)benzonitrile	-	-	440810120
797770	Cep-40783	-	-	440807295
797771	Ulixertinib	Clinical trial	PK:ERK	440810121
797772	Selonsertib	Clinical trial	PK:MAP3K5	440798966
797932	Plx8394	Clinical trial	PK:BRAF	440815545
797933	Tirabrutinib	Clinical trial	PK:BTK	440796096
797934	Plinabulin	Clinical trial	-	440801822
797937	Surufatinib	Clinical trial	PK:YK,FGFR,KDR	440804592
797938	Azd-5153	-	-	440815546
798200	Dubermatinib	Clinical trial	PK:AXL	440810122
798201	VH298	-	VHL	440798967
798202	Fenebrutinib	Clinical trial	PK:BTK	440804593
798303	N,N'-[sulfanediylbis(Ethane-2,1-Diyl-1,3,4-Thiadiazole-5,2-Diyl)]bis(2-Phenylacetamide)	-	GLS	440804594
798304	(8S,11R,13S,14S,17S)-11-(4-cyclopropylphenyl)-17-(1,1-difluoroprop-2-ynyl)-17-hydroxy-13-methyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one	-	MDM2	440798968
798517	2-(2-Chloro-6-fluorophenyl)-5-((4-(morpholine-4-carbonyl)phenyl)amino)oxazole-4-carboxamide	-	PK:TYK2	440798969
798799	Gs-9901	Clinical trial	-	440804595
798846	S63845	-	-	440807296
799644	DDP38003 trihydrochloride	-	-	440804596
799645	Ca-170	Clinical trial	-	440801824
799771	Linrodostat	Clinical trial	IDO1	440812865
799908	GNE-140 racemate	-	LDHA	440812866
800019	Pf-06821497	Clinical trial	EZH2	440810123
800030	Darovasertib	Clinical trial	PK:PRKCA	440801825
800283	H3b-6527	Clinical trial	PK:FGFR	440815547
800404	Pemrametostat	Clinical trial	PRMT5	440812867
800405	Umbralisib	FDA approved	-	440801826
800522	Repotrectinib	FDA approved	PK:ROS1,ALK	440815548
800525	Elimusertib	Clinical trial	PK:ATR	440812868
800729	Inavolisib	FDA approved	-	440812869
800888	Luvixasertib	Clinical trial	IDUA|PK:TTK	440804597
800890	[(2S)-2-(4-chlorophenyl)pyrrolidin-1-yl]-(3-methyl-2H-pyrazolo[3,4-b]pyridin-5-yl)methanone	-	PK:CDK	440815549
800892	Evobrutinib	Clinical trial	PK:BTK	440798970
800893	Milademetan	Clinical trial	MDM2	440810124
801082	Avapritinib	FDA approved	-	440812870
801089	Prn-1371	Clinical trial	PK:FGFR	440804598
801230	Bms-986158	Clinical trial	-	440798971
801661	TAK-931	Clinical trial	PK:CDC7	440812871
801812	Ciforadenant	Clinical trial	-	440798972
801813	Golidocitinib	Clinical trial	PK:JAK	440807297
801845	4-amino-1-[(2R,3S,4S,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)thiolan-2-yl]-1,3,5-triazin-2-one	-	-	459278582
802004	1-(2-Deoxy-2-fluoro-4-thio-arabinofuranosyl)cytosine	-	-	459276951
802100	Narazaciclib	Clinical trial	PK:CDK,RET	440812872
802101	Imaradenant	Clinical trial	-	440807298
802450	((2-((5-Fluoro-4-(4-fluoro-2-methoxyphenyl)pyridin-2-yl)amino)pyridin-4-yl)methyl)(imino)(methyl)-l6-sulfanone	Clinical trial	-	440801827
802451	Ly-3200882	Clinical trial	-	440801828
802548	Azd-5069	Clinical trial	CXCR2	440812873
802820	5-[2-(8-Oxa-3-azabicyclo[3.2.1]octan-3-yl)-9-pentan-3-ylpurin-6-yl]pyrazin-2-amine	-	PK:MTOR	440796097
802821	(S)-4-(Difluoromethyl)-5-(4-(3-methylmorpholino)-6-morpholino-1,3,5-triazin-2-yl)pyridin-2-amine	-	PK:MTOR	440807299
802822	Peposertib	Clinical trial	-	440796098
803014	Tenalisib	Clinical trial	-	440807300
803247	Numidargistat	Clinical trial	-	440798973
803248	N-[2-chloro-5-[4-(3-chloro-4-fluoroanilino)quinazolin-6-yl]pyridin-3-yl]methanesulfonamide	-	PK:EGFR	440815550
803408	Eed226	-	EED	440815551
803409	2-(3,5-difluoro-4-((3-(5-methoxy-4-((3-methoxypyridin-4-yl)amino)pyrimidin-2-yl)-1H-indazol-1-yl)methyl)phenoxy)ethan-1-ol	-	PK:BUB1	440798974
803410	Temuterkib	Clinical trial	PK:ERK	440804599
803552	GlyTouCan:G21349BB	Clinical trial	-	440796099
803600	Vorasidenib	FDA approved	IDH1|IDH2	440810125
803601	Cintirorgon	Clinical trial	-	440812874
803789	Azd-1390	Clinical trial	PK:ATM	440815552
803790	Starbld0041337	-	-	440807301
804040	Palupiprant	Clinical trial	-	440812875
804041	Tapotoclax	Clinical trial	-	440810126
804253	Pamiparib	Clinical trial	PARP1|PARP2	440812876
804254	6-(4-Amino-4-methylpiperidin-1-yl)-3-(2,3-dichlorophenyl)pyrazin-2-amine	-	PTPN11	440810127
804518	Rogaratinib	Clinical trial	PK:FGFR	440798975
804520	Siremadlin	Clinical trial	MDM2	440796100
804521	Epertinib	-	PK:EGFR,ERBB2	440804600
804861	Tolinapant	Clinical trial	IAP	440798976
804862	6-chloro-2-oxo-N-[(1S,5R)-8-[[1-(4,4,4-trifluorobutyl)piperidin-4-yl]methylsulfonyl]-8-azabicyclo[3.2.1]octan-3-yl]-1,3-dihydroindole-5-carboxamide	-	SMYD3	440807302
804962	Roblitinib	Clinical trial	PK:FGFR	440812877
805149	TP-3654	Clinical trial	PK:PIM1,PIM3	440798977
805500	SEL120-34A free base	-	PK:CDK	440801829
805596	2-(4-(Adamantan-1-yl)phenoxy)-1-(4-methylpiperazin-1-yl)ethanone	-	-	440807303
805746	4-((4-(cyclopentyloxy)-5-(2-methylbenzo[d]oxazol-6-yl)-7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)-3-methoxy-N-methylbenzamide	-	PK:TTK	440815553
806387	Fadraciclib	Clinical trial	PK:CDK	440807824
806388	Tasurgratinib	Clinical trial	PK:FGFR	440804912
806595	Plx-51107	Clinical trial	-	440812791
806812	Iadademstat	Clinical trial	-	440797048
807047	Naporafenib	Clinical trial	PK:RAF	440795968
807055	AZD5991	Clinical trial	-	440812490
807398	Incb-057643	Clinical trial	-	440802253
807626	JNJ-38877618	Clinical trial	-	440804391
807627	Branebrutinib	Clinical trial	PK:BTK	440815052
808292	Guadecitabine	Clinical trial	DNMT	440804219
808507	Onametostat	Clinical trial	PRMT5|PK:EGFR	440813202
808789	GDC-0575	Clinical trial	-	440807779
808790	Tizaterkib	Clinical trial	PK:ERK	440802330
808792	CC-90003	Clinical trial	PK:ERK	440807098
809099	Epz011989	-	EZH2	440808245
809100	Ro-5045337	-	MDM2	440805550
809251	Etc-159	Clinical trial	-	440796684
809252	Prmt5-IN-2	-	PRMT5	440804498
809693	Copanlisib	FDA approved	PK:PIK3	440799029
809694	Bos172722	Clinical trial	-	440804036
809970	Selitrectinib	Clinical trial	-	440815813
809971	MIK665	Clinical trial	-	440811100
809972	Iacs-010759	Clinical trial	-	440798403
809973	Orludodstat	Clinical trial	DHODH	440813314
810114	Vecabrutinib	Clinical trial	PK:BTK	440799990
810341	Pf-06459988	Clinical trial	PRMT5|PK:EGFR	440807806
810717	CG'806	Clinical trial	PK:BTK	440807215
811429	Pralsetinib	FDA approved	PK:RET	440795530
811953	6,6-Dimethyl-8-[7-(trifluoromethyl)imidazo[1,5-a]pyridin-5-yl]-1,3,8-triazaspiro[4.5]decane-2,4-dione	-	IDO1	440813079
812052	N-(tert-Butyl)-2-((6,6-dimethyl-8-(methylsulfonamido)-11-oxo-6,11-dihydronaphtho[2,3-b]benzofuran-3-yl)ethynyl)-6-methylisonicotinamide	-	-	440805155
812172	Ars-1620	-	KRAS	440801487
812415	ABBV-744	Clinical trial	-	440802131
812727	Relacorilant	FDA approved	-	440802777
812728	Azd-4320	-	-	440804384
812901	Rilzabrutinib	FDA approved	PK:BTK	440811061
812902	Gdc-0927	Clinical trial	-	440806897
812926	Zipalertinib	Clinical trial	PK:EGFR	440804705
812927	Ebvaciclib	Clinical trial	PK:CDK	440799083
812928	IDH305	Clinical trial	IDH1	440807507
813380	Ubavitinib	-	-	440801713
813381	DS-3201b	Clinical trial	EZH2	440812332
813488	Futibatinib	FDA approved	PK:FGFR	440796427
813783	Trabectedin	FDA approved	A2	440802362
813859	Abequolixron	Clinical trial	-	440798383
813862	Beta-Lapachone	Clinical trial	TOP2|TOP1	440812385
814025	Lsz-102	Clinical trial	SERD	440809861
816024	Incb054329	Clinical trial	-	440815726
816437	Copanlisib	FDA approved	-	440816497
816554	Azd-4573	Clinical trial	-	440796500
816555	Ro-6870810	Clinical trial	-	440795955
816556	Pemigatinib	FDA approved	-	440804240
816863	LY3295668	Clinical trial	-	440815048
816987	Trilaciclib	FDA approved	-	440795760
817040	Belvarafenib	Clinical trial	-	440810316
817041	Taminadenant	Clinical trial	-	440797093
817042	LY-3381916	Clinical trial	-	440798549
817043	Azd-7648	Clinical trial	-	440812305
818002	Mk-8353	Clinical trial	-	440798412
818003	Gusacitinib	Clinical trial	-	440798565
818432	M-3258	Clinical trial	-	440798552
818433	Sotorasib	FDA approved	-	440796328
818434	Selpercatinib	FDA approved	-	440798555
818435	PT2399	-	-	440798527
818619	Inobrodib	Clinical trial	-	440807030
818620	Odm-207	Clinical trial	-	440804300
818621	Olutasidenib	FDA approved	-	440808209
819210	(S)-N-(5-(2-(1-cyclopropylethyl)-7-(methylsulfonyl)-1-oxoisoindolin-5-yl)-4-methylthiazol-2-yl)acetamide	-	-	440806890
819211	Lhc-165	Clinical trial	-	440812602
819558	2-((S)-1-Acryloyl-4-(7-(8-methylnaphthalen-1-yl)-2-(((S)-1-methylpyrrolidin-2-yl)methoxy)-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-4-yl)piperazin-2-yl)acetonitrile	-	-	440798408
820052	E-7386	Clinical trial	-	440809833
820283	AB680 diammonium salt	Clinical trial	-	440802431
820784	Subasumstat	Clinical trial	-	440799577
820832	Elzovantinib	Clinical trial	-	440798529
820918	S-55746	Clinical trial	-	440798792
820919	4-methyl-3-(1-methyl-6-(pyridin-3-yl)-1H-pyrazolo(3,4-d)pyrimidin-4-ylamino)-N-(3-(trifluoromethyl)phenyl)benzamide	-	-	440807423
821656	Thz531	-	-	440810462
822744	Pulrodemstat	-	-	440809732
823658	Etrumadenant	Clinical trial	-	440812495
823659	Cb-103	Clinical trial	-	440815776
823806	GSK3368715	Clinical trial	-	440802233
823807	Zanubrutinib	FDA approved	-	440796275
824183	Bemcentinib	Clinical trial	-	440814994
824184	Emavusertib	Clinical trial	-	440799266
824722	Atm-3507	-	-	440801661
824723	Bay-293	-	-	440795818
825088	(R)-2-((3,5-dicyano-6-(dimethylamino)-4-ethylpyridin-2-yl)thio)-2-phenylacetamide	-	-	440807533
825089	Thz1	-	-	440804121
825217	Belzutifan	FDA approved	-	440799301
825254	Eribulin mesylate	FDA approved	-	440801555
825282	6-Isopropyl-7-oxo-5-phenyl-4,7-dihydropyrazolo[1,5-a]pyrimidine-3-carbonitrile	-	-	440802755
825286	BI-3406	-	-	440816002
825287	OG-L002	-	-	440813265
825331	Darolutamide	FDA approved	-	440796129
825332	N-((1S,9S)-9-Ethyl-5-fluoro-2,3,9,10,13,15-hexahydro-9-hydroxy-4-methyl-10,13-dioxo-1H,12H-benzo(de)pyrano(3',4':6,7)indolizino(1,2-b)quinolin-1-yl)-2-hydroxyacetamide	-	-	440804307
825519	Mobocertinib	FDA approved	-	440802469
825520	Deucravacitinib	FDA approved	-	440805236
825521	Odm-203	Clinical trial	-	440813474
825522	(4~{S})-4-ethyl-7,7-dimethyl-4-phenyl-2,6,8,9-tetrahydropyrazolo[3,4-b]quinolin-5-one	-	-	440807937
825523	Batoprotafib	Clinical trial	-	440816160
825713	Bay 2416964	Clinical trial	-	440800094
825775	Revumenib	FDA approved	-	440796922
825827	Cerdulatinib	Clinical trial	-	440800120
825956	Atamparib	Clinical trial	-	440799812
826039	Orelabrutinib	Clinical trial	-	440800033
826040	OT-82	Clinical trial	-	440797119
826119	PF-06952229	Clinical trial	-	440797111
826275	Lurbinectedin	FDA approved	-	440802518
826942	Auranofin	FDA approved	-	440813546
827275	Giredestrant	Clinical trial	-	440805393
827675	Amcenestrant	Clinical trial	-	440808421
827676	Jab-3068	Clinical trial	-	440816625
827802	4,5-Difluoro-2-[(6-imidazol-1-ylpyridazine-3-carbonyl)amino]benzoate	-	-	440813863
827886	Msc-2360844	Clinical trial	-	440814015
828250	Eragidomide	Clinical trial	-	440802509
828251	Bms-986142	Clinical trial	-	440799695
828252	Zanzalintinib	Clinical trial	-	440807963
828316	Vimseltinib	FDA approved	-	440816194
828317	5,6-Dimethylxanthenone-4-Acetic Acid	Clinical trial	-	440796775
828318	Pqr626	-	-	440799724
828319	Asn-007	Clinical trial	-	440796816
828583	4-(5,6-Dimethoxy-1-benzothiophen-2-yl)-4-oxobutanoic acid	-	-	440805582
828584	Zotatifin	Clinical trial	-	440797141
828717	Camizestrant	FDA approved	-	440802545
828852	N2-(3,5-dimorpholinophenyl)-N4-(1H-indazol-4-yl)-N4-methylpyrimidine-2,4-diamine	-	-	440811289
828853	CBP/p300-IN-8	-	-	440797285
828939	Tuxobertinib	Clinical trial	-	441612643
829066	Exatecan	Clinical trial	-	441613449
829498	Fruquintinib	FDA approved	-	441613247
830173	Mevociclib	Clinical trial	-	441614055
830201	Nemtabrutinib	Clinical trial	-	441612883
830202	(2R,4R)-1-[[5-chloro-2-[(3-cyanophenyl)methoxy]-4-[[3-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-methylphenyl]methoxy]phenyl]methyl]-4-hydroxypyrrolidine-2-carboxylic acid	-	-	441613877
830368	Flumatinib	Clinical trial	-	441612832
830911	Rineterkib	Clinical trial	-	441612801
830912	IPN-60090	Clinical trial	-	441613985
831147	TK216	Clinical trial	-	441613338
831270	Alrizomadlin	Clinical trial	-	441613161
831271	Jnj-63576253	-	-	441613761
831453	Adagrasib	FDA approved	-	443699379
831868	CB-5339	Clinical trial	-	443698476
832046	J81Gdr86J9	-	-	443698883
832261	Samuraciclib	Clinical trial	-	443699440
832262	4-(5-Methyl-4-(tosylmethyl)oxazol-2-yl)-N-(pyridin-3-ylmethyl)benzamide	-	-	443699552
832263	Monomethylauristatin E	Clinical trial	-	443698610
832522	Idrx-42	Clinical trial	-	443699273
832523	Anlotinib	Clinical trial	-	443698716
832772	LY3410738	Clinical trial	-	459277194
832937	Tegtociclib	Clinical trial	-	459278590
832938	PF-06939999	Clinical trial	-	459277772
833292	methyl (1S,3R)-2-(2-chloroacetyl)-1-(4-methoxycarbonylphenyl)-1,3,4,9-tetrahydropyrido[3,4-b]indole-3-carboxylate	-	-	459277627
833390	CID 155687064	-	-	459277077
833745	CID 137480383	-	-	459278422
833746	KA2507	Clinical trial	-	459278165
833899	Iberdomide	FDA approved	-	459277050
833900	5-Iminodaunorubicin	-	-	459278419
833901	2-(4-(4-(aminomethyl)-1-oxo-1,2-dihydrophthalazin-6-yl)-1-methyl-1H-pyrazol-5-yl)-3-fluoro-1-naphthonitrile	-	-	459278703
833973	Seclidemstat	Clinical trial	-	459278474
834160	Luxeptinib	Clinical trial	-	459277646
834161	Istisociclib	-	-	459278460
834196	Saruparib	Clinical trial	-	459278740
834197	Apg-1387	Clinical trial	-	459278456
834374	2-Amino-4-(4-(6-fluoro-5-methylpyridin-3-yl)phenyl)-5-oxo-4H,5H-pyrano[3,2-c]chromene-3-carbonitrile	-	-	459277103
834375	VOB560 HCl	-	-	459277916
835418	Art558	-	-	459277475
835419	Gpx4-IN-3	-	-	459278290
835563	Cirtuvivint	Clinical trial	-	459328201
835773	Pelcitoclax	Clinical trial	-	459636785
835774	n-(2-(1h-Indol-3-yl)ethyl)-9-isopropyl-2-(5-methylpyridin-3-yl)-9h-purin-6-amine	-	-	459636828
835775	2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide	-	-	459636907
835776	Gartisertib	Clinical trial	-	459636991
835817	AG-270	Clinical trial	-	459636909
835818	(R)-3-(4-Hydroxyphenyl)-3-(4-(trifluoromethoxy)phenyl)-7-(trifluoromethyl)indolin-2-one	-	-	459636738
836049	2,7-bis(piperidin-1-ylsulfonyl)-9H-fluoren-9-one oxime	-	-	461477656
836050	Bms-986115	Clinical trial	-	461477664
836163	Visudyne	FDA approved	-	461483243
836407	Mrtx-1133	Clinical trial	-	461593900
836439	Taletrectinib	FDA approved	-	461650707
836440	Beroterkib anhydrous	Clinical trial	-	461650696
836824	CID 138005723	-	-	461650746
836941	Incb-086550	Clinical trial	-	461663123
836942	Ard-2585	-	-	461663096
837081	2-((6-(4-Aminopiperidin-1-yl)-3,5-dicyano-4-ethylpyridin-2-yl)thio)-2-phenylacetamide	-	-	461823403
837082	N-(3-(4-fluorobenzenesulfonamido)-4-hydroxyphenyl)-(1,1'-biphenyl)-4-carboxamide	-	-	461823418
837396	Sy-5609	Clinical trial	-	462764937
837397	Monzosertib	-	-	462764921
837398	Azenosertib	Clinical trial	-	462764928
837893	Lisaftoclax	Clinical trial	-	463821130
838377	Triazadodecanoic acid methyl ester	-	-	464113151
838762	CID 146347307	-	-	464868654
838763	Cend-1	Clinical trial	-	464868809
839053	N-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)-N'-[4-(2-hydroxypropan-2-yl)furan-2-yl]sulfonylcarbamimidate	-	-	469398763
839102	3-amino-4-[(3S)-3-(2-ethoxyethoxymethyl)piperidin-1-yl]thieno[2,3-b]pyridine-2-carboxamide	-	-	469128523
839303	Triptolide	Clinical trial	-	469691020
839697	Resatorvid	Clinical trial	-	470142021
839698	Vociprotafib	Clinical trial	-	470142005
839699	Biib-091	Clinical trial	-	470141998
839865	Mrtx0902	Clinical trial	-	470142042
839866	Amg-650	Clinical trial	-	470142011
842817	PF-9363	-	-	523265921
843489	CTX-712	Clinical trial	-	475792893
843620	(3R,10R,14aS)-AZD4625	-	-	475973518
847060	5-{(5S)-1-[2-({3-chloro-6-[(2S)-2,4-dimethylpiperazin-1-yl]-2-fluoropyridin-4-yl}amino)-2-oxoethyl]-4-oxo-4,6,7,8-tetrahydro-1H-dipyrrolo[1,2-a:2',3'-d]pyrimidin-3-yl}-3,4-difluoro-2-hydroxybenzamide	-	-	482321894
847499	Braco-19	-	-	482740214
847500	Veludacigib	Clinical trial	-	482740209
847541	Novobiocin(Sodium)	FDA approved	-	483112273
847603	MRT-2359	Clinical trial	-	483124055
847604	Luxdegalutamide	Clinical trial	-	483124056
847763	Pemafibrate	Clinical trial	-	483127111
848001	M-3913	-	-	-
848059	N-Methyl-2-(phenanthro[2,3-D:5,6-D']bis([1,3]dioxole)-5-YL)ethanamine	-	-	-
848216	(4R)-1-{[4,4-Difluoro-1-(4-methoxyphenyl)cyclohexyl]carbonyl}-4-fluoro-N-1H-pyrazolo[4,3-B]pyridin-5-yl-D-prolinamide	-	-	-
848499	(2S,4R)-1-((S)-2-(2-(4-(3-amino-6-(2-hydroxyphenyl)pyridazin-4-yl)piperazin-1-yl)acetamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-((S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2-carboxamide	-	-	483561059
848927	N-(3-(6-Aminopyridazin-3-yl)prop-2-yn-1-yl)-2-(3,5-bis(trifluoromethyl)pyridin-2-yl)-N-(4-fluorophenyl)acetamide	-	-	483639544
848988	5-(4-Cyclohexylphenyl)-3-(3-(fluoromethyl)azetidine-1-carbonyl)-2-(3-methylpyrazin-2-yl)pyrazolo[1,5-a]pyrimidin-7(4H)-one	-	-	483761221
849264	LFHP-1c	-	-	483937282
849275	CFT1946	Clinical trial	-	483937287
850827	QN-302	Clinical trial	-	485512162
850891	CID 164603354	-	-	485512181
851765	A-485	-	-	485693497
851956	4-[(6-{4-[(3R)-3-({2,5,7-trimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-6-yl}oxy)pyrrolidin-1-yl]phenyl}pyridazin-3-yl)methyl]morpholine	-	-	485693512
851965	Elironrasib	Clinical trial	-	485948542
852143	C646	-	-	485979443
852342	Yap-tead-IN-3	Clinical trial	-	488357000
852481	Brigimadlin	Clinical trial	-	488356929
852513	Nms-873	-	-	488362903
852515	ML240	-	-	488362905
852671	Daraxonrasib	FDA approved	-	488448763
852727	TNG260	Clinical trial	-	488448767
852740	(S)-4-(3-(4-(4-Acryloylpiperazin-1-yl)-6-((S)-2,4-dimethylpiperazin-1-yl)pyridin-2-yl)-1,2,4-oxadiazol-5-yl)-2-amino-4-methyl-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carbonitrile	-	-	488929674
852741	N-(3-(((2-(6-Chloro-7-fluoro-1H-benzo[d]imidazol-2-yl)pyrimidin-4-yl)amino)methyl)pyridin-2-yl)-N-methylmethanesulfonamide	-	-	488929650
852742	FX-909	Clinical trial	-	488929653
852754	QC6352	-	-	488929690
852890	Dasatinib analog-1	-	-	489488428
852904	2-(2H-benzo[b][1,4]oxazin-4(3H)-yl)-N-benzyl-5,6,7,8-tetrahydroquinazolin-4-amine	-	-	489488447
852957	N-[(1S)-1-(6-amino-2-pyridinyl)ethyl]-5-[4-(trifluoromethyl)phenyl]-2-Naphthalenecarboxamide	-	-	490147820
852991	Exarafenib	Clinical trial	-	490147818
853210	LB-100	Clinical trial	-	491112472
853211	MX-69	-	-	491112385
853260	Gsk-2245035	Clinical trial	-	491673949
853293	Zidesamtinib	FDA approved	-	491673960
853395	Dt-2216	Clinical trial	-	491765485
853449	Cedazuridine	FDA approved	-	491791253
853556	(3S)-5-hydroxy-3-(2-(((1-((1-methylimidazol-4-yl)methyl)indol-6-yl)methylamino)methyl)-1H-indol-3-yl)-2,3-dihydroisoindol-1-one	-	-	494393609
853616	Prmt5-IN-25	-	-	495638768
853698	Mezigdomide	Clinical trial	-	495657851
853699	JAB-2485	Clinical trial	-	495657903
853759	(S)-6-(Furan-2-yl)-4-(2-methylpyrrolidin-1-yl)pyridazin-3-amine	-	-	496123145
853766	1-[(4-Phenoxyphenyl)methyl]-3-(1-prop-2-enoylpiperidin-3-yl)pyrido[3,2-d]pyrimidine-2,4-dione	-	-	496123148
853767	Ziftomenib	FDA approved	-	496123132
853808	Elraglusib	Clinical trial	-	496144112
853809	M1069 (free base)	Clinical trial	-	496144182
853817	AOH1996	Clinical trial	-	496144104
853818	Arn22089	-	-	496170901
853911	JNJ-64264681	Clinical trial	-	496170945
853962	Olomorasib	Clinical trial	-	496200726
853976	Docirbrutinib	Clinical trial	-	496200738
853978	Golcadomide hydrochloride	Clinical trial	-	496408207
853988	Abbv467 hydrate	Clinical trial	-	496408214
854009	5-{(5S)-1-[2-({3-chloro-6-[(2S)-2,4-dimethylpiperazin-1-yl]-2-fluoropyridin-4-yl}amino)-2-oxoethyl]-4-oxo-4,6,7,8-tetrahydro-1H-dipyrrolo[1,2-a:2',3'-d]pyrimidin-3-yl}-3,4-difluoro-2-hydroxybenzamide	-	-	496408205
854010	Elacestrant	FDA approved	-	496408252
854044	Rmc9799 hydrate	-	-	496703507
854151	Stat3-IN-25	-	-	497391913
854154	NXP900	Clinical trial	-	497399941
854170	Vlx-1570	Clinical trial	-	497400004
854208	Vactosertib	Clinical trial	-	497400086
854270	Tipiracil	FDA approved	-	497401454
854310	Bocodepsin Besylate	Clinical trial	-	497565136
854312	1-[3-(2,3-dichlorophenyl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-4-methylpiperidin-4-amine;hydrate;hydrochloride	-	-	497565220
854324	Rezatapopt	Clinical trial	-	497565178
854325	APG-2449	Clinical trial	-	497565189
854327	Hro-761	Clinical trial	-	497565183
854461	(S,E)-N-(1-Cyclopropyl-3-(methylsulfonyl)allyl)-2-(1,1-difluoroethyl)-4-phenoxypyrimidine-5-carboxamide	-	-	497628882
854462	Chk2-IN-2	-	-	497628912
854463	Rly-2608	Clinical trial	-	497628876
854531	Zongertinib	FDA approved	-	497648110
854563	Ifebemtinib	Clinical trial	-	500129595
854564	Zamaporvint	Clinical trial	-	500129547
854600	TAS2940	Clinical trial	-	500141157
854616	Rac1-IN-4	-	-	500141226
854633	AZD8421	Clinical trial	-	500141148
854781	Pan-FGFR Inhibitor KIN-3248	Clinical trial	-	503147787
854800	BTM-3566	Clinical trial	-	503147847
854801	PF-07284892	Clinical trial	-	503147815
854817	US20240116926, Example 38	-	-	503264709
854818	Atirmociclib	Clinical trial	-	503264696
854851	CID 72700713	Clinical trial	-	503268926
854872	5-(2-imidazo[1,2-b]pyridazin-3-ylethynyl)-N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]pyridine-3-carboxamide	-	-	503268888
854985	EC359	-	-	504065304
854987	(5Z)-5-(quinolin-6-ylmethylidene)-2-[(thiophen-2-ylmethyl)amino]-1,3-thiazol-4(5H)-one	-	-	504065301
854988	Rinzimetostat	Clinical trial	-	504065288
855177	BBI-355	Clinical trial	-	505080275
855286	TH9619 Hydrate	Clinical trial	-	504705304
855361	Dhodh-IN-16	Clinical trial	-	505080208
855373	Tersolisib	Clinical trial	-	505080084
855535	TYRA 300 besylate HYDRATE	Clinical trial	-	505059188
855559	XRD-0394	Clinical trial	-	505116522
855711	TNG348	Clinical trial	-	505377230
855878	Glecirasib	Clinical trial	-	505944446
855879	BAY-593 (hydrochloride)	-	-	505944452
856128	JAB-3312 3HCl	Clinical trial	-	507750908
856248	Cbl-b-IN-3	Clinical trial	-	508533171
856258	Zoldonrasib	Clinical trial	-	508533161
856465	VVD-130037	Clinical trial	-	513129259
856467	Namodenoson	Clinical trial	-	513129298
856500	ART6043	Clinical trial	-	513521463
856534	TNG462	Clinical trial	-	513521579